larg
bodi
evid
clearli
demonstr
protect
effect
breastfeed
document
transmiss
specif
infect
infant
breast
milk
fear
anxieti
aris
occurr
infecti
diseas
even
greater
situat
breastfeed
motherinf
dyad
uncertainti
lack
knowledg
often
lead
proscrib
breastfeed
fear
depriv
infant
potenti
protect
nutrit
emot
benefit
breastfeed
exactli
time
need
see
discuss
immunolog
benefit
human
milk
chapter
decis
concern
breastfeed
mother
infecti
ill
balanc
potenti
benefit
breastfeed
versu
known
estim
risk
infant
acquir
clinic
signific
infect
via
breastfeed
potenti
sever
infect
document
transmiss
infect
mother
infant
breastfeed
requir
exclus
possibl
mechan
transmiss
also
demonstr
infecti
agent
breast
milk
subsequ
clinic
signific
infect
infant
caus
plausibl
infecti
process
first
step
establish
occurr
specif
infect
clinic
immunolog
evid
mother
demonstr
persist
infecti
agent
could
transmit
infant
isol
identif
infecti
agent
colostrum
breast
milk
infecti
lesion
breast
import
necessarili
proof
transmiss
infant
epidemiolog
evid
transmiss
must
consid
includ
identifi
characterist
organ
relat
isol
infant
matern
isol
infecti
organ
reach
breast
milk
either
secret
fluid
cellular
compon
breast
milk
contamin
milk
time
express
reason
mechan
infect
via
breast
milk
evid
prove
either
anim
human
studi
demonstr
subclin
clinic
evid
infect
infant
follow
outlin
step
exclus
possibl
mechan
transmiss
exposur
mother
person
anim
via
airborn
droplet
arthropod
vector
mode
transmiss
direct
contact
infecti
fluid
would
complet
confirm
transmiss
infect
via
breastfeed
essenti
exclud
prenat
perinat
transmiss
infect
fetusinf
often
difficult
clinic
case
report
studi
confirm
isol
infecti
agent
milk
import
determin
reason
estim
risk
infect
via
breast
milk
larger
epidemiolog
studi
need
compar
infect
rate
breastf
infant
versu
formulaf
infant
robert
lawrenc
address
issu
identifi
time
breastfeed
import
rel
time
matern
infect
presenc
pathogen
colostrum
breast
milk
durat
breastfeed
anoth
import
variabl
consid
estim
risk
shed
pathogen
breast
milk
may
intermitt
consider
variabl
taken
account
gener
assess
risk
transmiss
infecti
agent
mother
infant
via
breast
milk
breastfeed
effort
prove
transmiss
infect
particular
maternalinf
dyad
difficult
must
consid
mani
factor
chapter
focus
discuss
specif
clinic
relev
infecti
agent
diseas
reason
estim
risk
infect
infant
breastfeed
basic
tenet
concern
breastfeed
infect
breastfeed
rare
contraind
matern
infect
except
relat
specif
infecti
agent
strong
evid
transmiss
associ
infant
ill
signific
morbid
mortal
risk
benefit
breastfeed
rel
immun
mother
infant
discuss
certain
microorgan
appendix
address
drug
breast
milk
includ
tabl
antiinfect
agent
chapter
review
breastfeed
may
protect
infect
chapter
address
specif
concern
relat
bank
breast
milk
includ
standard
develop
human
milk
bank
associ
north
america
guid
appropri
handl
bank
human
milk
rel
possibl
infecti
agent
isol
precaut
undergon
revis
terminolog
conceptu
understand
transmiss
microorgan
occur
known
infect
unrecogn
sourc
infect
recommend
made
standard
precaut
appli
patient
protect
health
care
worker
potenti
infecti
bodi
fluid
addit
precaut
base
predomin
mode
transmiss
recommend
protect
infect
airborn
rout
direct
contact
contact
droplet
although
precaut
intend
use
clinic
situat
protect
health
care
worker
may
appli
certain
situat
motherinf
dyad
prevent
transmiss
infecti
agent
one
hospit
mother
infant
precaut
use
often
mother
infant
still
hospit
use
precaut
within
home
meant
limit
breastfeed
intend
allow
breastfeed
major
case
facilit
continu
breastfeed
addit
safeguard
certain
situat
short
temporari
period
stop
breastfeed
safe
use
express
breast
milk
see
appendix
f
standard
precaut
includ
prevent
contact
blood
bodi
fluid
secret
excret
nonintact
skin
mucou
membran
care
handwash
everi
patient
contact
use
glove
touch
bodi
fluid
nonintact
skin
mucou
membran
item
contamin
bodi
fluid
linen
equip
devic
etc
use
nonsteril
gown
prevent
contact
cloth
bodi
fluid
use
mask
eye
protect
face
shield
splash
bodi
fluid
possibl
appropri
dispos
materi
standard
precaut
appli
patient
regardless
actual
perceiv
risk
center
diseas
control
prevent
cdc
consid
breast
milk
bodi
fluid
infecti
risk
thu
polici
appli
breast
milk
see
section
misadministr
breast
milk
later
chapter
possibl
except
concept
consid
breastfeed
infantmoth
dyad
standard
precaut
bodi
fluid
breast
milk
avoid
specifi
situat
breast
milk
also
avoid
gener
cloth
gown
mother
bandag
necessari
prevent
direct
contact
nonintact
skin
secret
avoid
infant
contact
matern
mucou
membran
requir
mother
awar
understand
risk
make
consciou
effort
avoid
type
contact
use
glove
gown
mask
infant
protect
neither
practic
appropri
recommend
concern
appropri
breastfeed
breast
milk
address
specif
infecti
agent
throughout
chapter
human
immunodefici
viru
hiv
infect
exampl
one
infect
prevent
use
standard
precaut
includ
avoid
breast
milk
breastfeed
recommend
concern
breastfeed
hiv
variou
variabl
consider
involv
discuss
later
airborn
precaut
intend
prevent
transmiss
via
droplet
nuclei
dri
respiratori
particl
smaller
mcm
contain
microorgan
remain
suspend
air
long
period
dust
particl
contain
microorgan
airborn
precaut
includ
use
privat
room
negativeairpressur
ventil
mask
time
case
pulmonari
tuberculosi
tb
respiratori
protect
devic
requir
person
fit
seal
test
use
worn
airborn
precaut
recommend
measl
varicella
dissemin
zoster
tb
breastfeed
presenc
matern
infect
prohibit
infecti
period
protect
airborn
transmiss
infect
mother
allow
infant
fed
mother
express
breast
milk
anoth
individu
except
allow
breast
milk
would
local
involv
breast
varicellazost
lesion
mycobacterium
tuberculosi
milk
becom
contamin
infecti
agent
transmiss
via
droplet
occur
individu
produc
droplet
travel
short
distanc
air
contact
new
host
eye
nose
mouth
skin
common
mechan
produc
droplet
includ
cough
sneez
talk
sing
yell
suction
intub
nasogastr
tube
placement
bronchoscopi
addit
standard
precaut
appli
patient
droplet
precaut
includ
use
privat
room
prefer
mask
within
feet
patient
droplet
precaut
recommend
adenoviru
diphtheria
respiratori
infect
haemophilu
influenza
neisseria
meningitidi
invas
infect
influenza
mump
mycoplasma
parvoviru
pertussi
plagu
pneumon
rubella
streptococc
pharyng
pneumonia
scarlet
fever
institut
droplet
precaut
breastfeed
mother
infect
specifi
particular
infect
may
requir
period
separ
infant
mother
durat
ill
shortterm
complet
treatment
mother
infecti
period
use
express
breast
milk
nutrit
interim
prophylact
treatment
infant
matern
use
mask
breastfeed
close
contact
combin
meticul
handwash
mother
avoid
touch
mucou
membran
may
adequ
reason
certain
infect
contact
precaut
meant
prevent
transmiss
infect
via
direct
contact
contact
bodi
surfac
one
individu
anoth
indirect
contact
contact
suscept
host
object
contamin
microorgan
anoth
individu
contact
precaut
includ
cohort
privat
room
glove
gown
time
handwash
remov
gown
glove
contact
precaut
recommend
long
list
infect
diarrhea
diaper
incontin
patient
clostridium
difficil
infect
escherichia
coli
shigella
rotaviru
hepat
respiratori
ill
parainfluenza
viru
respiratori
syncyti
viru
rsv
multidrugresist
mdr
bacteria
eg
enterococci
staphylococci
gramneg
organ
enterovir
infect
cutan
diphtheria
impetigo
herp
simplex
viru
hsv
infect
herp
zoster
dissemin
immunocompromis
individu
pediculosi
scabi
staphylococcu
aureu
skin
infect
viral
hemorrhag
fever
eg
ebola
lassa
conjunct
abscess
cellul
decubitu
contain
dress
breastfeed
infantmoth
dyad
implement
precaut
infect
mother
requir
meticul
attent
gown
handwash
mother
special
plan
situat
transmissionbas
precaut
use
togeth
organ
ill
transmit
one
rout
alway
use
conjunct
standard
precaut
recommend
patient
red
book
report
committe
infecti
diseas
american
academi
pediatr
aap
remain
excel
resourc
infect
control
guidelin
recommend
prevent
transmiss
specif
situat
infect
routin
cultur
breast
milk
cultur
breast
milk
screen
infecti
agent
recommend
except
milk
intend
donor
milk
anoth
mother
child
directli
human
milk
bank
see
chapter
specif
bacteri
count
standard
raw
donor
milk
pasteur
donor
milk
breastfeed
express
pump
breast
milk
refer
express
breast
milk
later
use
steril
activ
gener
express
breast
milk
contain
larg
number
microorgan
less
raw
milk
less
milk
pasteur
contain
potenti
pathogen
aureu
streptococci
pseudomona
speci
proteu
speci
streptococcu
faecali
faecium
studi
examin
routin
cultur
milk
signific
specif
bacteri
coloni
count
rel
ill
infant
studi
primarili
concern
prematur
lowbirthweight
lbw
infant
remain
hospit
commonli
fed
via
enter
tube
studi
canada
test
sampl
milk
use
preterm
infant
studi
identifi
advers
event
infant
attribut
organ
grow
milk
sampl
routin
bacteriolog
test
express
breast
milk
recommend
studi
chicago
examin
gramneg
bacilli
milk
use
prematur
infant
sampl
test
feed
nasogastr
tube
feed
milk
sampl
feed
less
like
contain
gramneg
bacilli
milk
sampl
nasogastr
tube
feed
intoler
observ
colonyform
unit
per
millilit
cfuml
episod
sepsi
identifi
bacteri
count
milk
greater
equal
cfuml
studi
recommend
routin
bacteriolog
test
express
breast
milk
anoth
studi
arkansa
focus
contamin
feed
tube
administr
express
breast
milk
formula
ten
infant
neonat
intens
care
unit
nicu
expos
greater
gramneg
bacteria
feed
tube
three
infant
fed
express
breast
milk
contamin
greater
organ
remain
well
seven
formulaf
infant
high
level
bacteri
contamin
feed
tube
develop
necrot
enterocol
gramneg
bacteria
high
level
contamin
feed
tube
either
enterobact
klebsiella
case
mani
nicu
consid
cfuml
signific
bacteri
count
gramneg
bacilli
breast
milk
place
prematur
lbw
infant
greater
risk
infect
even
less
data
avail
concern
specif
bacteri
coloni
count
gramposit
organ
risk
infant
gener
less
gramposit
organ
per
ml
milk
consid
accept
case
report
control
trial
support
cutoff
presenc
infecti
ill
infant
andor
breastfeed
mother
breast
breast
milk
serious
consid
possibl
mechan
transmiss
infant
cultur
breast
milk
identifi
organ
may
warrant
use
import
hurri
cultur
breast
milk
care
instruct
mother
proper
techniqu
collect
express
breast
milk
store
clean
collect
unit
reinforc
proper
techniqu
time
time
especi
question
contamin
aris
equal
import
mani
small
report
comment
contamin
breast
milk
differ
collect
method
rel
comparison
suggest
decreas
contamin
express
breast
milk
collect
follow
method
drip
milk
hand
pump
milk
manual
express
modern
electr
pump
milk
one
group
malaysia
publish
result
show
differ
contamin
milk
collect
electr
pump
versu
manual
express
collect
hospit
express
breast
milk
collect
home
breast
pump
higher
rate
contamin
staphylococci
gramneg
bacteria
discuss
continu
need
discard
first
millilit
milk
lower
bacteria
number
express
breast
milk
without
evid
suggest
truli
necessari
evid
show
cleans
breast
anyth
tap
water
decreas
bacteri
count
cultur
express
breast
milk
infant
directli
breastfeed
collect
milk
cultur
manual
express
tri
obtain
midstream
sampl
done
midstream
urin
collect
cultur
appropri
infant
fed
express
breast
milk
collect
cultur
milk
differ
point
collect
util
techniqu
mother
use
manual
express
hand
pump
electr
pump
administr
appropri
might
includ
sampl
immedi
collect
anoth
store
express
breast
milk
sampl
milk
recent
infant
feed
time
decis
cultur
made
pleas
see
box
basic
step
cultur
express
breast
milk
interpret
cultur
result
difficult
involv
pediatr
infecti
diseas
expert
microbiologist
hospit
epidemiologist
addit
organ
identif
often
requir
util
antibiogram
pattern
molecular
fingerprint
variou
techniqu
correl
bacteri
isol
breast
milk
isol
caus
diseas
infant
mother
misadministr
breast
milk
also
known
misappropri
breast
milk
exposur
accident
ingest
breast
milk
term
medicalleg
issu
occur
hospit
scenario
occur
one
infant
receiv
breast
milk
anoth
mother
mistak
occurr
distress
famili
recipi
patient
recipi
parent
donor
mother
medic
staff
involv
actual
risk
transmiss
infecti
agent
infant
via
singl
ingest
express
breast
milk
common
occurr
anoth
mother
exceedingli
low
scenario
cdc
recommend
treat
accident
exposur
bodi
fluid
could
infecti
bacteri
fungal
parasit
infect
one
exposur
highli
unlik
concern
viral
pathogen
known
bloodborn
pathogen
identifi
breast
milk
includ
limit
hepat
b
viru
hbv
hepat
c
viru
hcv
cytomegaloviru
cmv
west
nile
viru
human
tcell
lymphotrop
viru
htlv
hiv
hospit
protocol
manag
situat
infect
controlprevent
medicalleg
perspect
protocol
advis
inform
famili
occur
discuss
theoret
risk
harm
exposur
review
test
result
recommend
test
determin
infecti
statu
mother
rel
mention
virus
hcv
contraind
breastfeed
west
nile
viru
infect
lactat
women
rare
neither
infect
document
effect
form
prevent
acut
treatment
test
either
mother
donor
recipi
infant
agent
warrant
prenat
test
hiv
commonplac
throughout
world
incid
hiv
among
women
childbear
age
low
although
vari
significantli
geograph
locat
hospit
localespecif
incid
would
import
know
estim
risk
women
medic
staff
awar
hiv
transmit
breastfeed
therefor
breast
milk
hivposit
women
rare
ever
store
hospit
risk
transmiss
hiv
via
breastfeed
due
volum
feed
month
estim
feed
first
month
life
compar
small
dose
exposur
one
two
accident
feed
transmiss
hiv
singl
breast
milk
exposur
never
document
immunolog
compon
breast
milk
along
time
cold
storag
inactiv
hiv
express
breast
milk
reason
risk
transmiss
hiv
via
express
breast
milk
consum
anoth
child
thought
extrem
low
htlviii
infect
childbear
women
uncommon
except
certain
geograph
region
japan
africa
caribbean
south
america
transmiss
htlv
via
breast
milk
occur
like
hiv
appear
relat
volum
durat
breastfeed
limit
durat
breastfeed
effect
decreas
transmiss
freez
thaw
express
breast
milk
decreas
infect
htlvi
area
low
preval
posit
test
mother
suspect
fals
posit
test
retest
antibodi
polymeras
chain
reaction
pcr
test
perform
reason
transmiss
htlviii
via
accident
express
breast
milk
exposur
thought
extrem
low
although
major
women
cmv
posit
childbear
age
cmv
transmiss
occur
via
breastfeed
risk
cmv
fullterm
infant
low
prematur
lbw
infant
greater
risk
develop
diseas
cmv
infect
freez
express
breast
milk
c
day
significantli
decreas
infect
cmv
risk
cmv
transmiss
singl
accident
exposur
cmvposit
express
breast
milk
extrem
low
discuss
theoret
risk
discuss
possibl
prevent
intervent
vaccin
antimicrobi
postexposur
prophylaxi
donor
mother
posit
hbv
appropri
give
recipi
infant
hepat
b
viru
immunoglobulin
hbig
hbv
vaccin
alreadi
receiv
box
cultur
breast
milk
wash
hand
per
routin
wash
breast
warm
tap
water
clean
washcloth
manual
express
breast
milk
midstream
collect
requir
attach
breast
pump
flang
previous
clean
per
routin
collect
collect
milk
place
ml
sampl
express
breast
milk
steril
contain
nonleak
top
deliv
labatori
less
hour
refriger
c
deliveri
send
sampl
viral
lab
nucleic
acid
po
lymeras
chain
reaction
pcr
test
confirm
laboratori
accept
process
sampl
request
appropri
collect
contain
prelaboratori
manag
specimen
util
may
also
appropri
consult
pediatr
infecti
diseas
specialist
addit
import
compon
hospitalbas
protocol
manag
accident
express
breast
milk
exposur
includ
ongo
psychosoci
support
famili
staff
document
medic
discuss
famili
investig
step
consent
intervent
demonstr
ongo
infect
control
effort
prevent
addit
event
misadministr
breast
milk
microorgan
produc
whole
spectrum
clinic
ill
affect
mother
infant
mani
situat
carri
risk
transmiss
involv
organ
mother
infant
vice
versa
gener
howev
infant
greater
risk
factor
inoculum
size
immatur
immun
respons
alway
infect
must
accur
diagnos
time
manner
empir
therapi
initi
infect
control
precaut
begin
promptli
base
clinic
symptom
like
etiolog
agent
deal
matern
infect
clarifi
possibl
mode
transmiss
estim
rel
risk
transmiss
infant
essenti
first
step
decisionmak
isol
mother
infant
appropri
continu
breastfeed
provid
express
breast
milk
breastfeed
infrequ
contraind
specif
matern
infect
often
question
isol
interrupt
breastfeed
aris
symptom
fever
pain
inflamm
manifest
ill
first
develop
mother
diagnosi
still
doubt
clinic
judgment
must
made
base
site
infect
probabl
organ
involv
possibl
actual
mechan
transmiss
organ
infant
estim
virul
organ
like
suscept
infant
addit
time
ill
clearli
recogn
diagnos
mother
infant
alreadi
expos
given
dynam
natur
immunolog
benefit
breast
milk
continu
breastfeed
time
diagnosi
ill
mother
provid
infant
protect
rather
continu
exposur
ill
stop
breastfeed
rare
necessari
mani
situat
associ
matern
fever
requir
separ
mother
infant
engorg
breast
atelectasi
local
nonsuppur
phlebiti
urinari
tract
infect
appendix
f
list
number
clinic
syndrom
condit
organ
requir
infect
control
precaut
hospit
appendix
also
includ
short
list
possibl
etiolog
agent
condit
appropri
precaut
recommend
concern
breastfeed
differ
scenario
organ
chapter
consid
specif
infecti
agent
common
clinic
signific
particular
interest
bacillu
anthraci
gramposit
sporeform
rod
caus
zoonot
diseas
worldwid
human
infect
typic
occur
due
contact
anim
product
three
form
human
diseas
occur
cutan
anthrax
common
inhal
anthrax
gastrointestin
gi
diseas
rare
persontoperson
transmiss
occur
result
discharg
cutan
lesion
evid
humantohuman
transmiss
inhal
anthrax
avail
evid
transmiss
anthrax
via
breast
milk
exist
standard
contact
isol
appropri
hospit
patient
patient
drain
skin
lesion
issu
anthrax
biolog
weapon
exagger
import
caus
human
diseas
primari
concern
regard
anthrax
breastfeed
antimicrobi
therapi
prophylaxi
breastfeed
mother
possibl
infant
mother
expos
intent
aerosol
anthrax
spore
cdc
publish
recommend
treatment
prophylaxi
infant
children
breastfeed
mother
recommend
includ
use
ciprofloxacin
doxycyclin
amoxicillin
sever
agent
without
discontinu
breastfeed
littl
avail
inform
ciprofloxacin
doxycyclin
breast
milk
prolong
period
therapi
prophylaxi
day
possibl
effect
infant
teeth
bonecartilag
growth
time
period
depend
clinic
situat
sensit
test
identifi
anthrax
strain
agent
substitut
complet
cours
cdc
approv
use
ciprofloxacin
doxycyclin
breastfeed
women
short
cours
therapi
less
sever
week
simultan
exposur
infant
mother
could
occur
primari
aerosol
spore
contamin
local
environ
either
case
decontamin
motherinf
dyad
environ
consid
breastfeed
continu
mother
therapi
anthrax
long
physic
well
open
cutan
lesion
care
cover
depend
situat
simultan
prophylaxi
infant
may
appropri
consider
justifi
concern
express
report
sudden
infant
death
botul
infant
botul
distinguish
foodborn
botul
improperli
preserv
food
contain
toxin
wound
botul
spore
enter
wound
infant
botul
occur
spore
clostridium
botulinum
germin
multipli
gut
produc
botulin
toxin
gi
tract
toxin
bind
presynapt
neuromuscular
junction
prevent
acetylcholin
releas
clinic
pictur
descend
symmetr
flaccid
paralysi
everi
individu
c
botulinum
identifi
stool
experi
clinic
ill
age
infant
seem
relat
suscept
ill
ill
mainli
children
younger
month
age
youngest
patient
describ
literatur
day
old
children
becom
ill
week
month
age
onset
ill
seem
occur
earlier
formulaf
infant
compar
breastf
infant
previous
healthi
infant
younger
month
age
develop
constip
weak
difficulti
suck
swallow
cri
breath
botul
like
diagnosi
organ
look
stool
electromyographi
may
may
help
group
review
arnon
et
al
patient
hospit
california
still
nurs
onset
ill
benefici
effect
human
milk
observ
differ
mean
age
onset
breastf
infant
twice
old
formulaf
infant
diseas
breastf
infant
symptom
milder
breastf
infant
receiv
iron
supplement
develop
diseas
earlier
breastf
unsuppl
case
sudden
infant
death
botul
infant
breastf
within
week
death
receiv
ironfortifi
formula
case
specif
food
sourc
c
botulinum
identifi
honey
food
often
implic
corn
syrup
implic
infant
older
month
age
honey
may
contain
botul
spore
germin
infant
gut
howev
botulin
toxin
identifi
honey
recommend
honey
given
infant
younger
month
age
includ
put
honey
mother
nippl
initi
infant
interest
suckl
arnon
review
first
year
infant
botul
monitor
worldwid
diseas
report
state
unit
state
eight
countri
four
contin
relationship
breastfeed
human
milk
unclear
gener
acid
stool
ph
human
milk
fed
infant
encourag
bifidobacterium
speci
facult
anaerob
bacteria
clostridia
exist
spore
present
breastf
infant
contrast
formulaf
infant
stool
ph
rang
bifidobacteria
primarili
gramneg
bacteria
especi
coliform
bacteroid
speci
c
botulinum
growth
toxin
product
decreas
declin
ph
usual
stop
ph
breast
milk
also
contain
addit
protect
immunolog
compon
purportedli
activ
botulinum
toxin
relationship
introduct
solid
food
wean
formulaf
breastf
infant
onset
botul
remain
unclear
breastf
infant
introduct
solid
food
may
caus
major
chang
gut
rapid
rise
growth
enterobacteria
enterococci
follow
progress
colon
bacteroid
speci
clostridia
anaerob
streptococci
feed
solid
formulaf
infant
minim
chang
gut
flora
organ
alreadi
predomin
although
hospit
infant
breastf
suddendeath
victim
younger
formula
fed
support
concept
immunolog
protect
gut
breastf
infant
much
work
remain
understand
diseas
clinic
constip
weak
hypoton
previous
healthi
child
constitut
botul
rule
especi
recent
dietari
chang
time
reason
exist
suspect
breastfeed
risk
infant
botul
evid
suggest
possibl
protect
effect
breastfeed
breastfeed
continu
botul
suspect
mother
infant
brucella
melitensi
isol
milk
anim
food
anim
repres
primari
sourc
infect
human
brucellosi
demonstr
broad
spectrum
ill
human
subclin
subacut
chronic
ill
nonspecif
sign
weak
fever
malais
bodi
ach
fatigu
sweat
arthralgia
lymphaden
area
diseas
enzoot
childhood
ill
describ
frequent
clinic
manifest
children
similar
adult
infect
occur
pregnanc
lead
abort
infrequ
produc
transplacent
spread
caus
neonat
infect
rare
transmiss
b
melitensi
breast
milk
implic
neonat
infect
eight
case
brucellosi
infant
possibl
associ
breastfeed
brucella
isol
breast
milk
case
one
case
brucellosi
infant
caus
breast
milk
transmiss
b
melitensi
isol
breast
milk
antibiot
treatment
given
mother
document
addit
brucella
melitensi
cultur
women
breast
lump
abscess
one
six
women
describ
report
lactat
time
diagnosi
inform
infant
given
brucellosi
mastiti
abscess
consid
women
present
appropri
symptom
occup
exposur
anim
contact
domest
anim
environ
exposur
anim
milk
milk
product
especi
unpasteur
product
breast
inflamm
tend
granulomat
natur
without
caseat
often
associ
axillari
adenopathi
occasion
system
ill
woman
evid
treatment
brucellosi
mastiti
abscess
treat
surgeri
fine
needl
aspir
indic
week
combin
antibiot
therapi
two
three
medic
temporari
interrupt
breastfeed
breast
pump
discard
milk
continu
stimul
milk
product
appropri
breastfeed
continu
initi
period
hour
therapi
mother
accept
medic
treat
mother
continu
breastfeed
includ
gentamicin
streptomycin
tetracyclin
doxycyclin
trimethoprimsulfamethoxazol
rifampin
see
appendix
chlamydi
infect
frequent
sexual
transmit
diseas
std
unit
state
frequent
caus
conjunct
pneumon
infant
perinat
infect
major
determin
whether
chlamydi
infect
occur
newborn
preval
rate
chlamydi
infect
cervix
chlamydi
immunoglobulin
iga
found
colostrum
breast
milk
small
number
postpartum
women
seroposit
chlamydia
inform
avail
role
milk
antibodi
protect
infect
infant
believ
chlamydia
transmit
via
breast
milk
use
erythromycin
tetracyclin
treat
mother
oral
erythromycin
ophthalm
prepar
tetracyclin
erythromycin
sulfonamid
treat
suspect
infect
infant
appropri
continu
breastfeed
separ
infant
mother
chlamydi
infect
stop
breastfeed
indic
simultan
treatment
mother
infant
may
appropri
situat
corynebacterium
diphtheria
caus
sever
form
clinic
diseas
includ
membran
nasopharyng
obstruct
laryngotrach
cutan
infect
complic
includ
airway
obstruct
membran
format
toxinmedi
central
nervou
system
cn
diseas
myocard
overal
incid
diphtheria
declin
even
though
immun
prevent
infect
prevent
sever
diseas
toxin
product
fewer
five
case
report
annual
unit
state
transmiss
occur
via
droplet
direct
contact
contamin
secret
nose
throat
eye
skin
infect
occur
individu
whether
immun
infect
immun
sever
prolong
long
skin
breast
involv
risk
transmiss
exist
via
breast
milk
toxinmedi
diseas
toxin
transmit
breast
milk
report
infant
breastfeed
along
chemoprophylaxi
immun
affect
infant
appropri
absenc
cutan
breast
involv
see
appendix
f
matern
infect
neisseria
gonorrhoea
produc
larg
spectrum
ill
rang
uncompl
vulvovagin
proctiti
pharyng
conjunct
sever
invas
diseas
includ
pelvic
inflammatori
diseas
mening
endocard
dissemin
gonococc
infect
risk
transmiss
mother
infant
occur
mainli
deliveri
passag
infect
birth
canal
occasion
postpartum
contact
mother
partner
risk
transmiss
breast
milk
neglig
n
gonorrhoea
seem
caus
local
infect
breast
infect
neonat
often
ophthalmia
neonatorum
less
often
scalp
abscess
dissemin
infect
mother
presum
document
gonorrhea
reevalu
std
especi
chlamydia
trachomati
syphili
therapi
gonorrhea
adequ
either
infect
definit
identif
gonorrhea
mother
empir
therapi
begin
immedi
mother
separ
infant
complet
hour
adequ
therapi
treatment
mother
ceftriaxon
cefixim
penicillin
erythromycin
without
signific
risk
infant
singledos
treatment
spectinomycin
ciprofloxacin
ofloxacin
azithromycin
adequ
studi
presum
would
safe
infant
given
separ
delay
breastfeed
without
give
infant
express
breast
milk
pump
discard
doxycyclin
use
nurs
mother
routin
recommend
care
prevent
therapi
ophthalmia
neonatorum
provid
close
observ
infant
continu
day
usual
incub
period
empir
definit
therapi
n
gonorrhoea
may
necessari
depend
infant
clinic
statu
chosen
basi
matern
isol
sensit
pattern
mother
handl
infant
hour
adequ
therapi
infant
separ
rest
nurseri
popul
without
breastfeed
haemophilu
influenza
type
b
caus
sever
invas
diseas
mening
sinus
pneumonia
epiglott
septic
arthriti
pericard
bacteremia
shock
also
occur
increas
util
h
influenza
type
b
conjug
vaccin
invas
diseas
caus
haemophilu
decreas
dramat
unit
state
invas
diseas
occur
children
month
year
age
older
children
adult
rare
experi
sever
diseas
serv
sourc
infect
young
children
children
younger
month
age
seem
protect
passiv
acquir
antibodi
mother
addit
benefit
may
receiv
breast
milk
transmiss
occur
contact
respiratori
secret
droplet
precaut
protect
evid
suggest
transmiss
breast
milk
breastfeed
evid
support
breast
milk
limit
colon
h
influenza
throat
rare
case
matern
infect
inadequ
immun
infant
household
indic
provid
rifampin
prophylaxi
close
observ
household
contact
includ
breastfeed
infant
express
breast
milk
given
infant
separ
mother
initi
antimicrobi
therapi
mother
ill
prevent
breastfeed
reiniti
mother
abl
see
appendix
f
although
uncommon
unit
state
leprosi
occur
throughout
world
chronic
diseas
present
spectrum
symptom
depend
tissu
involv
typic
skin
peripher
nerv
mucou
membran
upper
respiratori
tract
cellular
immun
respons
caus
organ
mycobacterium
lepra
transmiss
occur
longterm
contact
individu
untreat
multibacillari
larg
number
organ
tissu
diseas
leprosi
contraind
breastfeed
accord
jeliff
jeliff
import
breastfeed
urgenc
treatment
recogn
expert
treat
infant
mother
earli
simultan
motherinf
contact
permit
except
breastfe
dapson
rifampin
clofazimin
typic
safe
use
infant
mother
regardless
method
feed
see
appendix
listeriosi
rel
uncommon
infect
broad
rang
manifest
immunocompet
individu
includ
pregnant
women
infect
vari
asymptomat
present
influenzalik
ill
occasion
gi
symptom
back
pain
sever
diseas
occur
frequent
immunodefici
individu
infant
infect
perinat
period
pneumonia
sepsi
mening
granulomatosi
infantisepticum
although
listeriosi
pregnanc
may
manifest
mild
diseas
mother
often
difficult
recogn
diagnos
typic
associ
stillbirth
abort
prematur
deliveri
thought
transmiss
occur
transplacent
hematogen
rout
infect
amniot
fluid
although
ascend
infect
genit
tract
may
occur
earli
effect
treatment
woman
prevent
fetal
infect
sequela
neonat
infect
occur
either
earlyor
lateonset
infect
transplacent
spread
late
pregnanc
ascend
infect
labor
deliveri
infect
passag
birth
canal
rare
postnat
exposur
evid
literatur
suggest
listeria
transmit
breast
milk
treatment
mother
ampicillin
penicillin
trimethoprimsulfamethoxazol
contraind
breastfeed
long
mother
well
enough
express
colostrum
breast
milk
also
given
infant
abl
feed
oral
manag
lactat
feed
neonat
listeriosi
conduct
support
situat
infant
extrem
ill
begin
feed
express
breast
milk
directli
breastfeed
soon
reason
n
meningitidi
often
caus
sever
invas
infect
includ
meningococcemia
mening
often
associ
fever
rash
progress
purpura
dissemin
intravascular
coagul
shock
coma
death
transmiss
occur
via
respiratori
droplet
spread
occur
infect
ill
individu
asymptomat
carrier
droplet
precaut
recommend
hour
initi
effect
therapi
despit
frequent
occurr
bacteremia
evid
indic
breast
involv
transmiss
breast
milk
risk
matern
infect
infant
birth
droplet
exposur
exist
whether
infant
breastfeed
bottl
feed
either
case
expos
infant
receiv
chemoprophylaxi
rifampin
mgkgdose
everi
hour
day
mgkgdose
infant
younger
month
age
ceftriaxon
mg
intramuscularli
im
children
younger
year
age
close
observ
infant
continu
day
breastfeed
prophylaxi
appropri
sever
matern
ill
may
prevent
breastfeed
continu
mother
abl
mother
infant
receiv
antibiot
hour
period
separ
index
case
first
hour
effect
therapi
recommend
express
breast
milk
given
period
respiratori
ill
caus
bordetella
pertussi
evolv
three
stage
catarrh
nasal
discharg
congest
increas
cough
paroxysm
sever
paroxysm
cough
sometim
end
inspiratori
whoop
ie
whoop
cough
convalesc
gradual
improv
symptom
transmiss
via
respiratori
droplet
greatest
risk
transmiss
occur
catarrh
phase
often
diagnosi
pertussi
nasopharyng
cultur
usual
becom
neg
day
antibiot
therapi
chemoprophylaxi
household
contact
routin
recommend
evid
indic
transmiss
breast
milk
similar
risk
breastf
bottlef
infant
case
matern
infect
pertussi
chemoprophylaxi
household
contact
regardless
age
immun
statu
indic
addit
chemoprophylaxi
infant
close
observ
subsequ
immun
infant
older
week
age
appropri
despit
chemoprophylaxi
droplet
precaut
separ
mother
infant
first
day
effect
matern
antibiot
therapi
recommend
express
breast
milk
provid
infant
period
staphylococc
infect
neonat
caus
either
aureu
coagulaseneg
staphylococci
often
epidermidi
manifest
wide
rang
ill
local
infect
impetigo
pustulosi
neonat
cellul
wound
infect
invas
suppur
diseas
includ
sepsi
pneumonia
osteomyel
arthriti
endocard
aureu
requir
small
inoculum
organ
produc
colon
newborn
often
nasal
mucosa
umbilicu
fifth
day
life
infant
nurseri
colon
aureu
organ
easili
transmit
other
mother
infant
famili
health
care
personnel
direct
contact
outbreak
nurseri
common
past
mother
infant
health
care
worker
even
contamin
unpasteur
bank
breast
milk
sourc
infect
care
use
antibiot
chang
nurseri
layout
procedur
standard
precaut
cohort
need
decreas
spread
aureu
nurseri
occurr
methicillinresist
aureu
mrsa
common
problem
requir
cohort
occasion
epidemiolog
investig
care
infect
control
intervent
numer
report
mrsa
outbreak
nicu
signific
colon
staphylococcu
factor
lead
develop
diseas
individu
patient
clear
morbid
mortal
relat
aureu
infect
neonat
well
describ
manag
outbreak
review
littl
written
role
breastfeed
colon
aureu
nicu
wellbabi
nurseri
home
mrsa
import
pathogen
worldwid
communityacquir
mrsa
differ
hospitalacquir
mrsa
communityacquir
mrsa
usual
defin
occur
individu
without
common
predispos
variabl
associ
hospitalacquir
mrsa
lack
mdr
phenotyp
common
hospitalacquir
mrsa
frequent
carri
multipl
exotoxin
virul
factor
pantonvalentin
leukocidin
toxin
well
carri
smaller
type
iv
staphylococc
cassett
cartridg
meca
gene
chromosom
hospitalacquir
mrsa
carri
type
iiii
staphylococc
cassett
cartridg
molecularli
distinct
common
nosocomi
strain
hospitalacquir
mrsa
communityacquir
mrsa
commonli
associ
skin
soft
tissu
infect
necrot
pneumonia
less
frequent
associ
endocard
bacteremia
necrot
fasciiti
myositi
osteomyel
parapneumon
effus
communityacquir
mrsa
common
observ
hospit
outbreak
communityacquir
mrsa
transmiss
infant
via
breast
milk
report
prematur
smallforgestationalag
infant
suscept
increas
risk
signific
morbid
mortal
due
mrsa
due
part
prolong
hospit
multipl
cours
antibiot
invas
procedur
intraven
iv
line
rel
immun
defici
due
prematur
ill
alter
gi
tract
due
differ
flora
decreas
gastric
acid
therefor
colon
mrsa
may
pose
greater
risk
infant
nicu
long
run
fullterm
infant
develop
pustulosi
cellul
soft
tissu
infect
rare
invas
diseas
report
fortunov
et
al
texa
report
infect
term
latepreterm
previous
well
infant
includ
pustulosi
cellulilti
abscess
invas
infect
famili
histori
soft
tissu
skin
infect
male
sex
variabl
associ
risk
infect
cesarean
deliveri
breastfeed
circumcis
nguyen
et
al
report
mrsa
infect
wellinf
nurseri
california
eleven
case
fullterm
boy
pustularvesicular
lesion
groin
infect
associ
longer
length
stay
lidocain
inject
use
infant
matern
age
older
year
circumcis
breastfeed
associ
risk
factor
mrsa
infect
question
role
circumcis
mrsa
outbreak
address
van
howe
robson
report
circumcis
boy
greater
risk
staphylococc
colon
infect
other
report
aureu
carriag
infant
subsequ
infect
like
affect
multipl
variabl
includ
infant
factor
antibiot
surgic
procedur
circumcis
common
durat
hospit
stay
newborn
matern
factor
previou
colon
previou
antibiot
usag
mode
deliveri
length
stay
environment
factor
mrsa
famili
hospit
nurseri
stay
versu
roomingin
hand
hygien
gerber
et
al
chicago
area
publish
consensu
statement
manag
mrsa
outbreak
nicu
recommend
strongli
support
experiment
clinic
epidemiolog
data
includ
use
waterless
alcoholbas
hand
hygien
product
monitor
enforc
hand
hygien
place
mrsaposit
infant
contact
precaut
cohort
possibl
use
glove
gown
direct
contact
mask
aerosolgener
procedur
cohort
nurs
care
mrsaposit
infant
possibl
period
screen
infant
mrsa
use
nare
nasopharyng
cultur
clarifi
mrsa
statu
infant
transfer
nicu
limit
overcrowd
maintain
ongo
instruct
monitor
health
care
worker
complianc
infect
control
hand
hygien
procedur
evalu
outbreak
could
includ
screen
health
care
worker
environment
surfac
corrobor
epidemiolog
data
laboratori
molecular
analysi
mrsa
strain
indic
epidemiolog
use
mupirocin
decolon
procedur
determin
individu
basi
nicu
aureu
common
caus
mastiti
lactat
women
recurr
persist
symptom
mastiti
well
describ
occurr
import
issu
manag
mastiti
communityacquir
mrsa
associ
mastiti
well
pasteur
aureu
detect
sampl
express
breast
milk
colon
one
infant
mrsa
identifi
mrsa
infect
identifi
hospit
infant
nicu
month
studi
novak
et
al
identifi
mrsa
sampl
express
freshfrozen
milk
differ
donor
five
brazilian
milk
bank
sampl
posit
highlevel
bacteri
count
mrsa
greater
cfuml
sampl
would
accept
bacteriolog
criteria
accord
brazilian
american
criteria
raw
milk
use
investig
epidemiolog
data
identifi
possibl
variabl
associ
low
high
level
contamin
express
breast
milk
mrsa
manag
infant
andor
mother
mrsa
infect
rel
breastfeed
use
breast
milk
base
sever
diseas
whether
infant
prematur
lbw
verylowbirthweight
vlbw
previous
ill
full
term
fullterm
infant
mother
develop
mild
moder
infect
impetigo
pustulosi
cellulitisabscess
mastitisbreast
abscess
soft
tissu
infect
continu
breast
feed
short
period
interrupt
hour
time
pump
maintain
milk
suppli
support
initi
evalu
evid
infect
done
maternalinf
dyad
infect
child
andor
mother
place
commonli
effect
therapi
mrsa
infect
ongo
observ
clinic
diseas
continu
mother
infant
roomin
togeth
hospit
necessari
standard
contact
precaut
cultur
breast
milk
necessari
empir
therapi
infant
may
chosen
base
medic
concern
infant
known
sensit
test
mrsa
isol
appropri
antibiot
choic
includ
shortterm
use
azithromycin
erythromycin
use
infanc
less
week
age
breastfeed
associ
increas
risk
hypertroph
pylor
stenosi
sulfamethoxazoletrimethoprim
absenc
defici
older
day
age
clindamycin
perhap
linezolid
mild
moder
infect
infant
nicu
prematur
lbw
vlbw
previous
ill
mother
mrsa
infect
breast
milk
cultur
suspend
breastfeed
receiv
breast
milk
mother
breast
milk
shown
cultur
neg
mrsa
infant
treat
indic
infect
empir
treat
symptomat
pend
cultur
result
close
observ
develop
new
sign
symptom
infect
pump
maintain
milk
suppli
use
bank
breast
milk
appropri
infant
place
contact
precaut
addit
routin
standard
precaut
infant
cohort
mrsaposit
infant
nurs
care
cohort
well
mother
mrsa
infect
instruct
concern
hand
hygien
care
collect
handl
storag
breast
milk
contact
precaut
use
infant
avoid
contact
infant
mother
receiv
sever
possibl
antibiot
mrsa
compat
breastfeed
use
short
period
mother
remain
clinic
well
includ
without
evid
mastiti
breast
milk
posit
mrsa
greater
cfuml
empir
therapi
diminish
erad
colon
would
appropri
variou
regimen
propos
erad
mrsa
colon
none
proven
highli
efficaci
regimen
usual
includ
system
antibiot
one
two
medic
rifampin
ad
second
medic
nasal
mupirocin
nare
twice
daili
week
routin
hygien
without
usag
hexachlorophen
similar
topic
agent
cleanser
bath
week
treatment
period
clear
inform
concern
efficaci
use
similar
colon
erad
regimen
household
member
pet
prevent
recolon
mother
infant
reintroduc
use
mother
breast
milk
infant
least
two
three
neg
breast
milk
cultur
obtain
complet
therapi
routin
screen
breast
milk
provid
mother
infant
nicu
presenc
mrsa
indic
absenc
mrsa
ill
maternalinf
dyad
mrsa
outbreak
nicu
high
frequenc
mrsa
infect
specif
nicu
one
case
staphylococc
scald
skin
syndrom
report
katzman
wald
infant
breastf
mother
lesion
areola
respond
ampicillin
therapi
day
subsequ
infant
develop
conjunct
aureu
produc
exfoli
toxin
confluent
erythemat
rash
without
mucou
membran
involv
nikolski
sign
attempt
identifi
exfoli
toxin
breast
milk
made
breast
milk
cultur
aureu
child
respond
iv
therapi
nafcillin
emphas
import
evalu
mother
infant
time
suspect
infect
need
continu
observ
infant
evid
pyogen
infect
toxinmedi
diseas
especi
matern
mastiti
breast
lesion
case
also
rais
issu
infant
mother
becom
colon
aureu
factor
lead
infect
ill
concern
staphylococcu
easili
transmit
skin
skin
contact
colon
readili
occur
potenti
seriou
ill
occur
later
long
colon
case
staphylococc
scald
skin
syndrom
toxic
shock
syndrom
tss
primari
site
infect
insignific
eg
conjunct
infect
circumcis
simpl
pustulosi
clinic
signific
amount
toxin
produc
lead
seriou
diseas
toxic
shock
syndrom
result
aureu
streptococcu
pyogen
infect
probabl
varieti
antigen
produc
organ
identifi
superantigen
affect
lymphocyt
compon
immun
respons
produc
unregul
excess
immun
respons
result
overwhelm
system
clinic
respons
tss
report
associ
vagin
deliveri
cesarean
deliveri
mastiti
local
infect
mother
mortal
rate
mother
may
high
case
definit
staphylococc
tss
includ
meet
four
major
criteria
fever
greater
c
rash
diffus
macular
erythroderma
hypotens
desquam
associ
subepiderm
separ
seen
skin
biopsi
definit
also
includ
involv
three
organ
system
gi
muscular
mucou
membran
renal
hepat
hematolog
central
nervou
system
neg
titer
rocki
mountain
spot
fever
leptospirosi
rubeola
lack
isol
pyogen
sourc
aureu
cerebrospin
fluid
csf
similar
case
definit
propos
streptococc
tss
aggress
empir
antibiot
therapi
staphylococci
streptococci
care
support
therapi
essenti
decreas
ill
death
oxacillin
nafcillin
firstgener
cephalosporin
clindamycin
erythromycin
vancomycin
accept
antibiot
even
breastfeed
mother
sever
ill
mother
may
preclud
breastfeed
reiniti
mother
improv
want
restart
standard
precaut
allow
breastfeed
recommend
staphylococc
enterotoxin
f
identifi
breast
milk
specimen
collect
day
mother
develop
tss
hour
postpartum
aureu
produc
staphylococc
enterotoxin
f
isol
mother
vagina
breast
milk
infant
mother
lack
signific
antibodi
staphylococc
enterotoxin
f
sera
infant
remain
healthi
day
followup
staphylococc
enterotoxin
f
pepsin
inactiv
ph
therefor
probabl
destroy
stomach
environ
present
littl
risk
breastfeed
infant
breastfeed
continu
mother
abl
coagulaseneg
staphylococc
infect
predomin
isol
staphylococcu
epidermidi
produc
minim
diseas
healthi
fullterm
infant
signific
problem
hospit
prematur
infant
factor
associ
increas
risk
infect
includ
prematur
high
colon
rate
specif
nurseri
invas
therapi
eg
iv
line
chest
tube
intub
antibiot
use
ill
produc
coagulaseneg
staphylococci
invas
sever
highrisk
neonat
rare
mother
report
necrot
enterocol
associ
coagulaseneg
staphylococcu
week
age
infant
still
nurseri
epidermidi
frequent
colon
organ
multipl
site
colon
rate
high
seriou
infect
coagulaseneg
staphylococci
eg
abscess
iv
line
infect
bacteremiasepsi
endocard
osteomyel
requir
effect
iv
therapi
mani
strain
resist
penicillin
semisynthet
penicillin
sensit
test
essenti
empir
definit
therapi
may
requir
treatment
vancomycin
gentamicin
rifampin
teicoplanin
linezolid
combin
synergist
activ
transmiss
infect
associ
breastfeed
appear
common
bottl
feed
aureu
infect
control
includ
contact
standard
precaut
occasion
presum
outbreak
care
epidemiolog
surveil
may
requir
includ
cohort
limit
overcrowd
understaf
surveil
cultur
infant
nurseri
personnel
reemphasi
meticul
infect
control
techniqu
individu
enter
nurseri
rare
remov
colon
personnel
direct
infant
contact
epidermidi
identifi
part
fecal
microbiota
breastf
infant
epidermidi
also
identifi
breast
milk
women
clinic
evid
mastiti
nevertheless
epidermidi
rare
associ
infect
fullterm
infant
conceiv
breast
milk
prematur
infant
could
sourc
epidermidi
colon
nicu
factor
associ
hospit
nicu
note
previous
presum
play
signific
role
colon
infect
prematur
infant
benefit
earli
full
human
milk
feed
potenti
outweigh
risk
colon
epidermidi
via
breast
milk
ongo
educ
assist
provid
mother
care
collect
storag
deliveri
human
breast
milk
prematur
infant
pyogen
group
streptococcu
ga
common
caus
skin
throat
infect
children
produc
pharyng
cellul
impetigo
ill
produc
ga
classifi
three
categori
impetigo
cellul
pharyng
without
invas
complic
sever
invas
infect
bacteremia
necrot
fasciiti
myositi
system
ill
eg
streptococc
tss
autoimmunemedi
phenomena
includ
acut
rheumat
fever
acut
glomerulonephr
ga
also
caus
puerper
sepsi
endometr
neonat
omphal
signific
morbid
mortal
rate
associ
invas
ga
infect
mortal
rate
almost
half
survivor
requir
extens
tissu
amput
infant
risk
autoimmun
sequela
ga
rheumat
fever
poststreptococc
glomerulonephr
transmiss
direct
contact
rare
indirect
contact
droplet
spread
outbreak
ga
nurseri
rare
unlik
staphylococc
infect
either
mother
infant
initi
colon
ga
transmit
situat
matern
ill
extens
cellul
necrot
fasciiti
myositi
pneumonia
tss
mastiti
appropri
separ
mother
infant
effect
therapi
penicillin
ampicillin
cephalosporin
erythromycin
given
least
hour
breastfeed
also
suspend
may
resum
hour
therapi
mother
group
b
streptococcu
gb
streptococcu
agalactia
signific
caus
perinat
bacteri
infect
parturi
women
infect
lead
asymptomat
bacteriuria
urinari
tract
infect
often
associ
prematur
birth
endometr
amnion
infant
infect
usual
occur
birth
month
age
case
per
live
birth
routin
classifi
time
onset
ill
infant
earli
onset
day
major
less
hour
late
onset
day
gener
less
week
infant
may
develop
sepsi
pneumonia
mening
osteomyel
arthriti
cellul
earlyonset
gb
diseas
often
fulmin
present
sepsi
pneumonia
respiratori
failur
three
quarter
neonat
diseas
earli
onset
type
iii
common
serotyp
caus
diseas
transmiss
believ
occur
utero
deliveri
colon
rate
mother
infant
vari
postpartum
transmiss
thought
uncommon
although
document
risk
factor
earlyonset
gb
diseas
includ
deliveri
week
gestat
ruptur
membran
longer
hour
deliveri
intrapartum
fever
heavi
matern
colon
gb
low
concentr
antigb
capsular
antibodi
matern
sera
common
occurr
sever
gb
diseas
hour
age
neonat
lead
prevent
strategi
revis
guidelin
develop
aap
committe
infecti
diseas
fetu
newborn
tri
combin
variou
variabl
increas
risk
gb
infect
prenat
colon
gb
obstetr
neonat
risk
factor
earlyonset
diseas
provid
intrapartum
prophylaxi
high
risk
figur
util
guidelin
intrapartum
prophylaxi
across
unit
state
decreas
incid
earlyonset
diseas
approxim
incid
earlyonset
diseas
case
per
live
birth
lateonset
gb
diseas
thought
result
transmiss
deliveri
postnat
period
matern
hospit
commun
sourc
dillon
et
al
demonstr
infant
lateonset
diseas
colon
birth
sourc
colon
unidentifi
other
gardner
et
al
show
children
cultur
neg
gb
discharg
hospit
acquir
gb
month
age
anthoni
et
al
note
mani
infant
colon
gb
actual
attack
rate
gb
diseas
low
difficult
predict
acquisit
gb
breast
milk
breastfeed
uncommon
case
lateonset
gb
diseas
associ
gb
matern
milk
report
mother
bilater
mastiti
least
one
delay
evid
unilater
mastiti
other
asymptomat
clear
colon
infant
occur
infect
diseas
began
infant
author
discuss
possibl
infant
origin
colon
deliveri
subsequ
colon
mother
breast
breastfeed
becam
reinfect
later
time
butter
demoor
show
infant
initi
colon
head
birth
gb
cultur
throat
nose
umbilicu
day
later
whenev
cultur
gb
nippl
mother
author
also
found
nose
throat
infant
byrn
et
al
present
review
gb
diseas
associ
breastfeed
made
recommend
decreas
risk
transmiss
gb
infant
via
breastfeed
breast
milk
recommend
includ
confirm
appropri
collect
process
procedur
gb
cultur
medic
facil
decreas
falseneg
cultur
review
proper
hygien
pump
collect
storag
express
breast
milk
mother
review
sign
symptom
mastiti
mother
util
bank
human
milk
need
instead
mother
milk
breastf
infant
develop
lateonset
gb
diseas
appropri
cultur
milk
see
discuss
cultur
breast
milk
earlier
chapter
consid
treatment
mother
prevent
reinfect
milk
cultur
posit
gb
greater
cfuml
without
clinic
evid
mastiti
mother
withhold
mother
milk
confirm
cultur
neg
pathogen
appropri
accompani
provid
ongo
support
instruct
mother
concern
pump
maintain
milk
suppli
serial
cultur
express
breast
milk
treatment
mother
gb
diseas
colon
would
appropri
insur
ongo
absenc
pathogen
express
breast
milk
report
reinfect
infant
breast
milk
erad
gb
mucos
colon
infant
mother
may
difficult
author
recommend
use
rifampin
prophylact
mother
infant
end
treatment
erad
mucos
colon
see
chapter
manag
mastiti
mother
mother
infant
colon
infect
gb
manag
standard
precaut
hospit
ongo
close
evalu
infant
infect
ill
empir
therapi
gb
infant
appropri
child
remain
well
cultur
subsequ
neg
hour
occasion
epidemiolog
investig
hospit
util
cultur
medic
staff
famili
member
detect
sourc
lateonset
gb
diseas
nurseri
use
one
case
lateonset
diseas
detect
serotyp
cohort
situat
may
appropri
select
prophylact
therapi
colon
infant
erad
colon
may
consid
unlik
ga
staphylococcu
infect
gb
infect
nurseri
report
caus
outbreak
data
support
screen
breastfeed
mother
express
breast
cbc
includ
wbc
count
differenti
blood
cultur
appli
penicillin
ampicillin
cefazolin
assum
recommend
dose
regimen
healthyappear
infant
week
gestat
deliveri
whose
mother
receiv
hour
iap
deliveri
may
discharg
home
hour
discharg
criteria
met
person
abl
compli
fulli
instruct
home
observ
present
one
condit
met
infant
observ
hospit
least
hour
criteria
discharg
achiev
milk
gb
reason
method
protect
spread
gb
infect
via
express
breast
milk
select
cultur
express
breast
milk
may
appropri
certain
situat
face
tuberculosi
tb
chang
throughout
world
unit
state
incid
tb
rose
declin
sinc
increas
rate
tb
note
adult
year
age
primari
childbear
year
risk
transmiss
children
increas
tb
pregnanc
alway
signific
concern
patient
physician
alik
clear
cours
prognosi
tb
pregnanc
less
affect
pregnanc
determin
locat
extent
diseas
defin
primarili
chest
radiograph
suscept
individu
patient
untreat
tb
pregnanc
associ
matern
infant
mortal
rate
effect
therapi
crucial
clinic
outcom
pregnant
nonpregn
women
tb
pregnanc
rare
result
congenit
tb
individu
highrisk
group
tb
screen
tuberculin
skin
test
tst
contraind
alter
respons
tst
exist
pregnanc
breastfeed
interpret
tst
follow
recent
guidelin
use
differ
size
indur
differentrisk
popul
cutoff
posit
test
propos
cdc
figur
outlin
evalu
treatment
pregnant
woman
posit
tst
treatment
activ
tb
begin
soon
diagnosi
made
regardless
fetu
gestat
age
risk
diseas
mother
fetu
clearli
outweigh
risk
treatment
isoniazid
rifampin
ethambutol
use
safe
three
trimest
isoniazid
pyridoxin
therapi
breastfeed
safe
although
risk
hepatotox
mother
may
concern
first
month
postpartum
congenit
tb
extrem
rare
one
consid
million
case
tb
occur
year
worldwid
less
case
congenit
tb
report
literatur
infecti
diseas
present
perinat
period
distinguish
congenit
infect
perinat
postnat
tb
infant
difficult
postnat
tb
infect
infanc
typic
present
sever
diseas
extrapulmonari
extens
mening
lymphadenopathi
bone
liver
spleen
involv
airborn
transmiss
tb
infant
major
mode
postnat
infect
close
prolong
exposur
enclos
space
especi
household
adult
infecti
pulmonari
tb
potenti
infecti
sourc
could
mother
adult
caregiv
babysitt
day
care
worker
rel
friend
neighbor
even
health
care
worker
suspicion
tb
infect
diseas
household
possibl
exposur
infant
highli
anxietyprovok
situat
figur
although
protect
infant
infect
foremost
everyon
mind
separ
infant
mother
avoid
reason
everi
situat
uniqu
best
approach
vari
accord
specif
case
accept
principl
tb
manag
first
step
care
potenti
expos
infant
determin
accur
true
tb
statu
suspect
case
mother
household
contact
prompt
evalu
includ
complet
histori
previou
tb
infect
diseas
previou
ongo
tb
treatment
tst
statu
symptom
suggest
activ
tb
result
recent
chest
radiograph
sputum
smear
cultur
physic
examin
tst
indic
new
chest
radiograph
mycobacteri
cultur
smear
suspect
site
infect
household
contact
evalu
promptli
includ
histori
tst
evalu
indic
continu
risk
infant
occur
infecti
household
contact
effect
evalu
treat
infant
separ
temporarili
suspect
sourc
symptom
suggest
activ
diseas
recent
tst
document
convers
separ
continu
result
chest
radiograph
seen
consider
variabl
cours
ill
concomit
infecti
period
debat
continu
without
adequ
data
appropri
period
separ
individu
given
specif
situat
hiv
test
assess
risk
mdr
tb
done
everi
case
activ
tb
sensit
test
done
everi
mycobacterium
tuberculosi
isol
tabl
summar
manag
newborn
infant
whose
mother
household
contact
tb
initi
prophylact
isoniazid
therapi
infant
demonstr
effect
prevent
tb
infect
diseas
infant
therefor
continu
separ
infant
mother
unnecessari
therapi
mother
child
begun
real
risk
infant
requir
separ
airborn
transmiss
separ
infant
mother
activ
pulmonari
tb
appropri
regardless
method
feed
howev
mani
part
world
therapi
mother
prophylaxi
isoniazid
infant
begun
infant
mother
separ
without
separ
mother
infant
continu
close
observ
throughout
cours
matern
therapi
ensur
good
complianc
medic
mother
infant
identifi
earli
symptom
infant
suggest
tb
tubercul
mastiti
occur
rare
unit
state
occur
part
world
lead
infect
infant
frequent
involv
tonsil
mother
usual
singl
breast
mass
associ
axillari
lymph
node
swell
infrequ
develop
drain
sinu
tb
breast
also
present
painless
mass
edema
involv
breast
occur
without
evid
diseas
site
evalu
extent
diseas
appropri
includ
lesion
cultur
needl
aspir
biopsi
wedg
resect
milk
cultur
therapi
multipl
antitb
medic
surgeri
supplement
need
remov
extens
necrot
tissu
persist
drain
sinu
neither
breastfeed
breast
milk
feed
done
lesion
heal
usual
week
continu
antitb
therapi
month
mother
isoniazid
infant
month
indic
absenc
tubercul
breast
infect
mother
transmiss
tb
breast
milk
document
thu
even
though
temporari
separ
infant
mother
may
occur
pend
complet
evalu
initi
adequ
therapi
mother
prophylact
isoniazid
therapi
mgkgday
singl
daili
dose
infant
breast
milk
express
given
infant
short
separ
breastfeed
safe
continu
whether
mother
infant
receiv
antitb
therapi
antitb
medic
isoniazid
rifampin
pyrazinamid
aminoglycosid
ethambutol
ethionamid
paminosalicyl
acid
safe
use
infanc
therefor
presenc
medic
smaller
amount
breast
milk
contraind
breastfeed
although
conflict
report
indic
breastfeed
tstposit
mother
influenc
infant
respons
bacil
note
workup
alway
includ
evalu
tb
statu
household
close
contact
tuberculin
skin
test
tst
review
symptom
physic
examin
chest
xray
cxr
sputum
smear
cultur
done
indic
separ
occur
interpret
cxr
film
confirm
absenc
activ
diseas
activ
diseas
separ
continu
individu
longer
consid
infecti
three
neg
consecut
sputum
smear
adequ
ongo
empir
therapi
decreas
fever
cough
sputum
product
separ
mean
differ
hous
locat
simpli
separ
room
household
durat
separ
individu
case
consult
tb
specialist
assum
evid
breast
involv
suspect
tb
mastiti
lesion
except
statu
breast
involv
consid
risk
infant
via
aerosol
bacteria
sputum
lung
express
breast
milk
given
even
separ
mother
infant
advis
tst
posit
symptom
physic
find
suggest
tb
neg
cxr
film
prophylact
therapi
isoniazid
mgkgday
maximum
mg
month
pyridoxin
mgday
month
empir
therapi
standard
threeor
fourdrug
regimen
month
treatment
continu
total
month
isoniazid
rifampin
organ
shown
sensit
suspect
multidrugresist
mdr
tb
requir
consult
tb
specialist
select
optimum
empir
regimen
ongo
monitor
therapi
clinic
respons
vaccin
tst
perhap
tuberculosi
bacillu
despit
effort
identifi
either
solubl
substanc
specif
cell
fraction
gammadelta
cell
colostrum
breast
milk
affect
infant
immun
respons
unifi
theori
explain
variou
report
chang
evid
identifi
consist
clinic
signific
effect
viral
infect
arbovirus
arbovirus
origin
larg
collect
virus
group
togeth
common
mode
transmiss
arthropod
reclassifi
sever
differ
famili
bunyavirida
togavirida
flavivirida
reovirida
other
includ
human
pathogen
organ
primarili
produc
either
cn
infect
enceph
meningoenceph
undifferenti
ill
associ
fever
rash
sever
hemorrhag
manifest
involv
organ
hepat
myalgia
polyarthr
infect
array
virus
may
also
asymptomat
subclin
although
often
occur
uncertain
notabl
human
pathogen
includ
bunyavirida
california
serogroup
virus
hantaviru
hantaan
viru
phleboviru
rift
valley
fever
nairoviru
crimeancongo
hemorrhag
fever
alphaviru
western
eastern
venezuelan
equin
encephalomyel
virus
chikungunya
viru
flaviviru
st
loui
enceph
viru
japanes
enceph
viru
dengu
virus
yellow
fever
viru
tickborn
enceph
virus
orbiviru
colorado
tick
fever
crimeancongo
hemorrhag
fever
report
case
colorado
tick
fever
associ
transfus
direct
persontoperson
spread
rare
describ
recent
outbreak
chikungunya
viru
infect
reunion
island
india
describ
infect
young
infant
probabl
secondari
vertic
spread
mother
infant
transplacent
case
earli
fetal
death
associ
infect
pregnant
women
case
vertic
transmiss
occur
nearterm
infect
mother
infant
develop
ill
within
day
deliveri
evid
transmiss
via
breast
milk
breastfeed
avail
littl
evid
indic
organ
transmit
breast
milk
except
includ
evid
transmiss
two
flavivirus
via
breast
milk
west
nile
viru
yellow
fever
vaccin
viru
standard
precaut
gener
suffici
infect
breastfeed
mother
sever
ill
may
determin
mother
abil
continu
breastfeed
provid
infant
express
breast
milk
accept
see
discuss
west
nile
viru
yellow
fever
vaccin
viru
later
chapter
gener
treatment
ill
support
howev
ribavirin
appear
decreas
sever
mortal
hantaviru
pulmonari
syndrom
hemorrhag
fever
renal
failur
crimeancongo
hemorrhag
fever
ribavirin
describ
teratogen
variou
anim
speci
contraind
pregnant
women
inform
avail
concern
ribavirin
breast
milk
littl
inform
avail
use
iv
oral
ribavirin
infant
arenavirus
singlestrand
ribonucl
acid
rna
virus
infect
rodent
acquir
human
rodent
six
major
human
pathogen
group
lymphocyt
sensit
test
done
posit
cultur
isoniazid
mgkgday
month
depend
mother
contact
statu
repeat
tst
month
obtain
normal
cxr
infant
stop
isoniazid
begin
therapi
workup
infant
congenit
activ
tb
may
appropri
workup
determin
clinic
statu
infant
suspect
potenti
risk
may
includ
tst
week
age
cxr
complet
blood
count
erythrocyt
sediment
rate
liver
function
test
cerebrospin
fluid
analysi
gastric
aspir
sonographycomput
tomographi
liverspleen
chest
congenit
tb
suspect
breastfeed
proscrib
separ
mother
infant
indic
risk
aerosol
transmiss
bacteria
express
breast
milk
given
infant
via
bottl
accept
absenc
mastiti
breast
lesion
consult
tb
specialist
mdr
tb
empir
therapi
chosen
base
recent
cultur
sensit
index
patient
perhap
suspect
sourc
case
known
well
medic
toxic
factor
tb
mastiti
usual
involv
singl
breast
associ
axillari
lymph
node
swell
infrequ
drain
sinu
tract
also
present
painless
mass
edema
breast
suspect
mastiti
breast
lesion
caus
tb
even
breast
milk
contraind
lesion
mastiti
heal
usual
week
patient
document
recent
tst
convers
complet
evalu
evalu
begin
cxr
done
evalu
less
hour
minim
separ
person
infant
workup
proceed
indic
symptom
physic
find
cxr
result
choriomening
viru
lassa
fever
viru
junin
viru
argentin
hemorrhag
fever
machupo
viru
bolivian
hemorrhag
fever
guanarito
viru
venezuelan
hemorrhag
fever
sabia
viru
geograph
distribut
virus
ill
caus
determin
live
rang
host
rodent
reservoir
exact
mechan
transmiss
human
unknown
hotli
debat
direct
contact
aerosol
rodent
excret
secret
probabl
mechan
lymphocyt
choriomening
viru
well
recogn
europ
america
area
perinat
matern
infect
lead
sever
diseas
newborn
evid
suggest
transmiss
breast
milk
standard
precaut
breastfeed
appropri
lassa
fever
west
africa
argentin
hemorrhag
fever
argentin
pampa
usual
sever
ill
dramat
bleed
involv
organ
includ
brain
fever
frequent
lead
shock
death
form
hemorrhag
fever
caus
virus
group
persontoperson
spread
lassa
fever
believ
common
transmiss
within
household
occur
may
relat
prolong
viremia
excret
viru
urin
human
day
possibl
persist
viru
human
urin
semen
blood
infect
exist
arenavirus
possibl
airborn
transmiss
undecid
current
recommend
cdc
use
contact
precaut
durat
ill
situat
suspect
viral
hemorrhag
fever
substanti
inform
describ
infect
variou
bodi
fluid
includ
breast
milk
differ
viral
hemorrhag
fever
consid
sever
ill
mother
risk
infant
reason
avoid
breastfeed
situat
altern
form
infant
nutrit
provid
inform
becom
avail
reassess
recommend
advis
vaccin
clinic
trial
endem
area
junin
viru
argentin
hemorrhag
fever
preliminari
studi
suggest
effect
data
still
accumul
concern
vaccin
use
children
pregnant
breastfeed
women
cytomegaloviru
cmv
one
human
herpesvirus
congenit
infect
infant
postnat
infect
prematur
infant
infect
immunodefici
individu
repres
seriou
form
infect
children
time
viru
infect
fetu
infant
presenc
absenc
antibodi
cmv
mother
import
determin
sever
infect
likelihood
signific
sequela
congenit
infect
syndrom
deaf
chorioretin
abnorm
neurodevelop
learn
disabl
infant
born
excret
cmv
birth
approxim
congenit
infect
infant
demonstr
evid
infect
birth
approxim
five
symptomat
case
per
live
birth
approxim
infant
born
primari
infect
pregnant
woman
manifest
least
one
sequela
prenat
infect
variou
studi
detect
pregnant
women
cmv
cervic
cultur
pregnant
women
cmv
urin
perinat
infect
certainli
occur
contact
viru
fluid
usual
associ
clinic
ill
fullterm
infant
lack
ill
thought
result
transplacent
passiv
transfer
protect
antibodi
mother
postnat
infect
later
infanc
occur
via
breastfeed
contact
infect
fluid
eg
saliva
urin
rare
caus
clinic
ill
fullterm
infant
seroepidemiolog
studi
document
transmiss
infect
infanc
higher
rate
transmiss
occur
daycar
center
especi
preval
cmv
urin
saliva
high
cmv
identifi
milk
cmvseroposit
women
vari
rate
use
viral
cultur
cmv
deoxyribonucl
acid
dna
pcr
cmv
often
identifi
breast
milk
seroposit
mother
vagin
fluid
urin
saliva
cmv
isol
rate
colostrum
lower
matur
milk
reason
larg
degre
variabl
identif
cmv
breast
milk
studi
probabl
relat
intermitt
natur
reactiv
excret
viru
addit
variabl
frequenc
durat
sampl
breast
milk
differ
studi
author
hypothes
differ
isol
rate
breast
milk
fluid
caus
viral
reactiv
cell
leukocyt
monocyt
breast
lead
select
excret
breast
milk
vochem
et
al
report
rate
virolactia
greatest
week
postpartum
yeager
et
al
report
signific
virolactia
week
postpartum
antibodi
eg
secretori
iga
cmv
present
breast
milk
along
variou
cytokin
protein
eg
lactoferrin
may
influenc
viru
bind
cell
prevent
transmiss
infect
sever
studi
document
increas
rate
postnat
cmv
infect
breastf
infant
compar
bottlef
infant
observ
first
year
life
studi
fullterm
infant
acquir
cmv
infect
postnat
rare
mildli
symptomat
time
seroconvers
document
viral
excret
also
evid
late
sequela
cmv
found
infant
postnat
exposur
suscept
infant
cmv
includ
prematur
infant
without
passiv
acquir
matern
antibodi
cmv
infant
born
cmvseroneg
mother
immunodefici
infant
caus
signific
clinic
ill
pneumon
hepat
thrombocytopenia
one
studi
prematur
infant
follow
month
vochem
et
al
found
cmv
transmiss
infant
expos
cmv
virolactia
breastf
compar
infant
infect
expos
breast
milk
without
cmv
infant
given
cmvseroposit
donor
milk
blood
five
infant
develop
cmv
infect
month
age
mild
sign
ill
includ
transient
neutropenia
one
infant
short
increas
episod
apnea
period
thrombocytopenia
five
prematur
infant
cmv
infect
month
age
acut
ill
includ
sepsislik
symptom
apnea
bradycardia
hepat
leukopenia
prolong
thrombocytopenia
vollmer
et
al
follow
prematur
infant
earli
postnat
cmv
infect
acquir
breast
milk
year
assess
neurodevelop
hear
function
none
children
sensorineur
hear
loss
differ
cmvinfect
children
match
prematur
control
cmvneg
infant
term
neurolog
speech
languag
motor
develop
neuberg
et
al
examin
symptom
neonat
outcom
cmv
infect
transmit
via
human
milk
prematur
infant
casecontrol
fashion
cmvinfect
prematur
infant
compar
cmvneg
match
prematur
infant
neutropenia
thrombocytopenia
cholestasi
associ
cmv
infect
infant
seriou
effect
ill
found
directli
associ
infect
includ
intraventricular
hemorrhag
periventricular
leukomalacia
retinopathi
prematur
necrot
enterocol
bronchopulmonari
dysplasia
durat
mechan
ventil
oxygen
therapi
durat
hospit
stay
weight
gestat
age
head
circumfer
time
discharg
exposur
cmvseroneg
prematur
infant
cmvposit
milk
donor
natur
mother
avoid
variou
method
inactiv
cmv
breast
milk
report
includ
holder
pasteur
freez
c
day
brief
high
temperatur
c
second
one
small
prospect
studi
suggest
freez
breast
milk
hour
protect
prematur
infant
cmv
infect
via
breast
milk
sharland
et
al
report
prematur
infant
less
week
uninfect
birth
expos
breast
milk
cmv
seroposit
mother
one
infant
becam
posit
cmv
day
life
infant
clinic
asymptomat
transmiss
rate
consider
lower
other
report
literatur
cmvseroneg
leukocytedeplet
blood
product
use
routin
bank
breast
milk
pasteur
store
c
variou
time
period
matern
express
breast
milk
frozen
c
use
whenev
possibl
infant
receiv
breast
milk
median
day
rang
day
observ
median
day
rang
day
breast
milk
sampl
preor
postfreez
analyz
pcr
cultur
presenc
cytomegaloviru
buxmann
et
al
demonstr
transmiss
cmv
prematur
infant
receiv
thaw
frozen
breast
milk
week
gestat
age
postnat
age
less
equal
week
gestat
age
born
mother
cmvigg
neg
cmv
infect
found
five
prematur
infant
infant
born
mother
cmvigg
posit
provid
breast
milk
infant
three
five
children
remain
asymptomat
one
child
develop
respiratordepend
pneumonia
second
develop
upper
respiratori
tract
infect
thrombocytopenia
associ
cmv
infect
yasuda
et
al
report
preterm
infant
median
gestat
age
week
demonstr
peak
cmv
dna
copi
detect
realtim
pcr
assay
breast
milk
week
postpartum
thirti
infant
receiv
cmv
dnaposit
breast
milk
three
cmv
dna
detect
sera
none
three
symptom
suggest
cmv
infect
much
breast
milk
store
c
feed
author
propos
probabl
reason
less
transmiss
cohort
lee
et
al
report
use
matern
milk
frozen
minimum
hour
feed
prematur
infant
nicu
infant
cmvseroposit
mother
infant
cmvseroneg
mother
two
infant
develop
cmv
infect
symptomat
fed
frozen
thaw
milk
cmvseroposit
mother
other
report
individu
case
cmv
infect
prematur
infant
despit
freez
thaw
breast
milk
simpl
freez
thaw
breast
milk
complet
prevent
transmiss
cmv
prematur
infant
efficaci
freez
thaw
breast
milk
vari
length
time
prevent
cmv
infect
prematur
infant
studi
prospect
random
control
trial
eleven
neonat
unit
sweden
milk
bank
freez
matern
milk
reduc
risk
cmv
transmiss
prematur
infant
promin
group
neonatologist
pediatr
infecti
diseas
expert
california
recogn
signific
benefit
provid
human
milk
prematur
lbw
infant
recommend
screen
mother
prematur
infant
cmv
igg
deliveri
infant
mother
cmv
igg
posit
deliveri
use
either
pasteur
bank
human
milk
frozen
thaw
matern
breast
milk
prematur
infant
reach
age
week
consider
low
rate
cmv
virolactia
colostrum
predomin
occurr
virolactia
week
peak
week
postpartum
reason
propos
begin
colostrum
breast
milk
feed
infant
matern
cmv
serolog
screen
complet
appropri
recommend
close
observ
followup
prematur
infant
older
week
age
sign
symptom
laboratori
chang
cmv
infect
discharg
hospit
cmvseroposit
mother
safe
breastfe
fullterm
infant
despit
higher
rate
cmv
infect
formulaf
infant
observ
first
year
life
infect
situat
associ
signific
clinic
ill
sequela
dengu
virus
serotyp
dengu
flavivirus
associ
primarili
febril
ill
rash
dengu
fever
dengu
hemorrhag
fever
dengu
shock
syndrom
mosquito
aed
aegypti
main
vector
transmiss
dengu
viru
countri
lie
latitud
degre
north
degre
south
billion
peopl
live
area
transmiss
occur
dengu
viru
infect
million
individu
year
casus
approxim
death
year
although
dengu
hemorrhag
fever
dengu
shock
syndrom
occur
frequent
children
younger
year
age
infrequ
describ
infant
younger
month
age
also
differ
clinic
laboratori
find
dengu
viru
infect
children
compar
adult
boussemart
et
al
report
two
case
perinatalprenat
transmiss
dengu
discuss
eight
addit
case
neonat
literatur
prenat
intrapartum
transmiss
type
dengu
mother
confirm
serolog
cultur
pcr
phongsamart
et
al
describ
three
addit
case
dengu
viru
infect
late
pregnanc
appar
transmiss
two
three
infant
passiv
acquisit
antibodi
third
infant
sirinavin
et
al
report
case
literatur
vertic
dengu
infect
present
less
week
age
observ
discuss
breast
milk
breastfeed
potenti
sourc
infect
publish
watanaveeradej
et
al
present
addit
three
case
dengu
infect
infant
document
normal
growth
develop
followup
month
age
postul
sever
diseas
associ
dengu
diseas
occur
individu
specif
igg
serotyp
infect
strain
set
concentr
lead
antibodydepend
enhanc
infect
presenc
preexist
dengu
serotyp
specif
igg
infant
impli
either
previou
primari
infect
serotyp
passiv
acquisit
igg
mother
previou
primari
infect
serotyp
perhap
acquisit
specif
igg
breast
milk
watanaveeradej
et
al
document
transplacent
transfer
antibodi
four
serotyp
dengu
viru
cord
sera
deliveri
followup
infant
document
loss
antibodi
dengu
viru
time
loss
month
age
respect
evid
avail
literatur
sever
diseas
breastf
infant
compar
formulaf
infant
interhuman
transmiss
dengu
viru
absenc
mosquito
vector
evid
transmiss
via
breast
milk
known
one
report
factor
lipid
portion
breast
milk
inhibit
dengu
viru
avail
evid
antibodi
activ
dengu
viru
human
breast
milk
known
breastfeed
matern
infant
dengu
diseas
continu
determin
mother
infant
sever
ill
epsteinbarr
viru
ebv
common
infect
children
adolesc
young
adult
usual
asymptomat
notabl
caus
infecti
mononucleosi
associ
chronic
fatigu
syndrom
burkitt
lymphoma
nasopharyng
carcinoma
ebv
one
human
herpesvirus
concern
rais
lifelong
latent
infect
potenti
risk
infect
fetu
neonat
mother
primari
ebv
infect
pregnanc
unusu
pregnant
women
suscept
although
abort
prematur
birth
congenit
infect
ebv
suspect
distinct
group
anomali
link
ebv
infect
fetu
neonat
also
virolog
evid
ebv
caus
abnorm
found
associ
suspect
ebv
infect
cultur
ebv
variou
fluid
site
difficult
viru
detect
capac
transform
b
lymphocyt
persist
lymphoblastoid
cell
line
pcr
dna
hybrid
studi
detect
ebv
cervix
breast
milk
one
studi
identifi
ebv
dna
breast
milk
cell
women
donat
milk
breast
milk
bank
demonstr
antibodi
ebv
igg
igm
anoth
studi
examin
serolog
specimen
breastf
bottlef
infant
show
similar
seropreval
ebv
month
age
breastf
bottlef
children
respect
question
time
ebv
infect
subsequ
immun
respons
clinic
diseas
produc
requir
continu
studi
differ
exist
among
clinic
syndrom
manifest
differ
age
infant
young
children
asymptomat
ill
recogn
relat
ebv
mild
episod
ill
includ
fever
lymphadenopathi
rhiniti
cough
hepatosplenomegali
rash
adolesc
young
adult
experi
primari
ebv
infect
often
demonstr
infecti
mononucleosi
syndrom
asymptomat
chronic
fatigu
syndrom
common
adolesc
young
adult
burkitt
lymphoma
observ
primarili
africa
nasopharyng
carcinoma
seen
southeast
asia
primari
ebv
infect
usual
occur
young
children
tumor
associ
earli
ebv
infect
tumor
relat
chronic
ebv
infect
tend
occur
individu
persist
high
antibodi
titer
ebv
viral
capsid
antigen
earli
antigen
question
tumor
occur
much
greater
frequenc
geograph
area
cofactor
includ
alter
immun
respons
infect
associ
coinfect
immun
escap
ebv
lead
malign
increas
resist
apoptosi
secondari
ebv
gene
mutat
may
contribut
develop
remain
unansw
also
remain
unknown
degre
breast
milk
could
sourc
earli
ebv
infect
compar
sourc
ebv
infect
infant
environ
similar
situat
postnat
transmiss
cmv
immunocompet
infant
clinic
signific
ill
rare
associ
primari
ebv
infect
infant
data
concern
pathogenesi
ebvassoci
tumor
obtain
proscrib
breastfeed
warrant
especi
area
tumor
common
protect
benefit
breastfeed
high
area
burkitt
lymphoma
nasopharyng
carcinoma
uncommon
ebv
infect
mother
infant
certainli
contraind
breastfeed
marburg
ebola
virus
caus
sever
highli
fatal
hemorrhag
fever
ill
often
present
nonspecif
symptom
conjunct
frontal
headach
malais
myalgia
bradycardia
progress
worsen
hemorrhag
shock
subsequ
death
patient
persontoperson
transmiss
direct
contact
droplet
spread
airborn
spread
common
mode
transmiss
howev
anim
reservoir
sourc
virus
natur
human
infect
identifi
attack
rate
famili
postexposur
intervent
prove
use
prevent
spread
treatment
support
current
avail
recent
report
document
presenc
ebola
viru
numer
bodi
fluid
includ
breast
milk
one
acut
breast
milk
sampl
day
onset
ill
convalesc
breast
milk
sampl
day
woman
posit
ebola
viru
cultur
pcr
test
studi
saliva
remain
viru
posit
mean
day
diseas
onset
urin
posit
mean
day
semen
mean
day
onset
diseas
inform
avail
concern
risk
transmiss
virus
breast
milk
addit
risk
benefit
breastfeed
contact
precaut
recommend
marburg
viru
infect
contact
airborn
precaut
ebola
viru
infect
given
high
attack
mortal
rate
precaut
care
institut
breastfeed
allow
suitabl
sourc
nutrit
found
infant
express
breast
milk
also
proscrib
infant
mother
either
infect
least
week
postrecoveri
diagnosi
hepat
pregnant
woman
nurs
mother
caus
signific
anxieti
first
issu
determin
etiolog
hepat
allow
inform
discuss
risk
fetusinf
differenti
diagnosi
acut
hepat
includ
common
caus
hepat
hepat
b
c
igm
antihbcag
antihcv
initi
diagnost
test
simultan
consider
etiolog
acut
liver
dysfunct
appropri
depend
patient
histori
initi
diagnost
test
neg
subsequ
addit
test
antihepat
viru
hdv
hcv
rna
hepati
g
viru
hgv
rna
antihepati
e
viru
hev
hev
rna
may
necessari
initi
test
reveal
posit
hbsag
test
antihdv
hbeag
hbv
dna
appropri
addit
test
use
defin
prognosi
mother
risk
infect
infant
diagnost
evalu
appropri
discuss
mother
parent
theoret
risk
transmit
infecti
agent
caus
hepat
via
breastfeed
discuss
includ
evalu
posit
neg
effect
suspend
continu
breastfeed
exact
etiolog
diagnosi
determin
rel
risk
transmiss
infect
infant
estim
specif
prevent
measur
provid
infant
tabl
hepat
viru
hav
usual
acut
selflimit
infect
ill
typic
mild
gener
subclin
infant
occasion
hav
infect
prolong
relaps
extend
month
rare
fulmin
hav
infect
lead
chronic
infect
incid
prematur
matern
hav
infect
increas
evid
date
indic
obviou
birth
defect
congenit
syndrom
hav
infect
prematur
infant
may
lead
prolong
viral
shed
transmiss
often
person
person
fecalor
transmiss
foodborn
waterborn
epidem
describ
transmiss
via
blood
product
vertic
transmiss
mother
infant
rare
transmiss
daycar
set
clearli
describ
infect
hav
newborn
uncommon
seem
signific
problem
usual
period
viral
shed
presum
contagi
last
week
acut
matern
hav
infect
last
trimest
postpartum
period
could
lead
infect
infant
symptomat
infect
prevent
immunoglobulin
ig
administr
diseas
prevent
ig
administr
immun
serum
globulin
within
week
exposur
hav
vaccin
administ
simultan
ig
without
affect
seroconvers
rate
produc
rapid
prolong
hav
serum
antibodi
level
transmiss
hav
via
breast
milk
implic
one
case
report
data
exist
frequenc
isol
hav
breast
milk
hav
infect
infanc
rare
usual
subclin
without
chronic
diseas
exposur
alreadi
occur
time
etiolog
diagnosi
hepat
mother
made
reason
exist
interrupt
breastfeed
matern
hav
infect
infant
receiv
ig
hav
vaccin
administ
simultan
hepat
b
viru
hbv
infect
lead
broad
spectrum
ill
includ
asymptomat
seroconvers
nonspecif
symptom
fever
malais
fatigu
clinic
hepat
without
jaundic
extrahepat
manifest
arthriti
rash
renal
involv
fulmin
hepat
chronic
hbv
infect
chronic
hbv
infect
occur
infant
infect
via
perinat
vertic
transmiss
children
infect
year
age
given
increas
risk
signific
sequela
chronic
infect
chronic
activ
hepat
chronic
persist
hepat
cirrhosi
primari
hepatocellular
carcinoma
prevent
hbv
infect
infanc
crucial
transmiss
hbv
usual
blood
bodi
fluid
stool
semen
saliva
urin
cervic
secret
vertic
transmiss
either
transplacent
perinat
deliveri
well
describ
throughout
world
vertic
transmiss
rate
area
hbv
endem
taiwan
japan
high
wherea
transmiss
infant
hbv
carrier
mother
area
hbv
carrier
rate
low
uncommon
transmiss
hbv
infant
occur
infant
mother
acut
infect
immedi
soon
pregnanc
hbsag
found
breast
milk
transmiss
rout
well
document
beasley
beasley
et
al
demonstr
although
breast
milk
transmiss
possibl
seroconvers
rate
differ
breastf
nonbreastf
infant
longterm
followup
studi
hbsagposit
mother
hill
et
al
follow
breastf
infant
formulaf
infant
born
women
chronic
hbsag
posit
infant
receiv
hepat
b
immunoglobulin
birth
full
seri
hepat
b
vaccin
none
breastf
infant
nine
formulaf
infant
posit
hbsag
complet
hbv
vaccin
seri
breastfeed
occur
mean
month
rang
week
year
transmiss
happen
probabl
occur
labor
deliveri
anoth
report
china
follow
infant
born
hbsagposit
women
infant
receiv
appropri
dose
time
hbig
hbv
vaccin
year
age
antihb
antibodi
present
breastf
infant
bottlef
infant
risk
factor
associ
immunoprophylaxi
failur
vertic
transmiss
hbv
includ
hbeagseroposit
mother
elev
hbv
dna
viral
load
mother
aap
committe
infecti
diseas
state
breastfeed
infant
hbsagposit
mother
pose
addit
risk
acquisit
hbv
infect
infant
appropri
administr
hepat
b
vaccin
hbig
screen
pregnant
women
hbv
infect
essenti
first
step
prevent
vertic
transmiss
univers
hbv
vaccin
birth
infanc
administr
hepat
b
immunoglobulin
hbig
immedi
birth
infant
hbsagposit
mother
prevent
hbv
transmiss
case
breastfeed
hbsagposit
women
contraind
immedi
administr
hbig
hbv
vaccin
occur
two
subsequ
dose
vaccin
given
appropri
interv
dosag
specif
hbv
vaccin
product
decreas
small
theoret
risk
hbv
transmiss
breastfeed
almost
zero
acut
peripartum
postpartum
hepat
occur
mother
hbv
infect
possibl
associ
increas
risk
transmiss
infant
discuss
mother
parent
identifi
potenti
risk
benefit
continu
breastfeed
etiolog
hepat
determin
appropri
altern
sourc
nutrit
avail
infant
breast
milk
withheld
etiolog
hepat
identifi
hbig
hbv
vaccin
administ
infant
alreadi
immun
document
immun
hbv
acut
hbv
infect
document
mother
breastfeed
continu
immun
begun
acut
infect
hcv
indistinguish
hepat
b
infect
howev
typic
asymptomat
mild
hcv
infect
major
caus
bloodborn
nona
nonb
hepat
nanbh
chronic
hcv
infect
report
occur
time
regardless
age
time
infect
sequela
chronic
hcv
infect
similar
associ
chronic
hbv
infect
bortolotti
et
al
two
commonli
identifi
mechan
transmiss
hcv
transfus
blood
blood
product
iv
drug
use
howev
rout
transmiss
exist
hcv
infect
occur
even
absenc
obviou
direct
contact
signific
amount
blood
bodi
fluid
contamin
blood
probabl
serv
sourc
infect
transmiss
sexual
contact
occur
infrequ
probabl
requir
addit
contribut
factor
coinfect
sexual
transmit
agent
high
viral
load
serum
bodi
fluid
studi
transmiss
household
without
risk
factor
demonstr
either
low
rate
transmiss
transmiss
report
rate
vertic
transmiss
vari
wide
mother
unknown
hiv
statu
known
hiv
infect
rate
vertic
transmiss
wherea
rate
vari
known
hivneg
mother
studi
suggest
matern
coinfect
hiv
hcv
genotyp
activ
matern
liver
diseas
serum
titer
matern
hcv
rna
may
associ
increas
rate
vertic
transmiss
correl
hcv
viremia
hcv
viral
load
mother
vertic
transmiss
hcv
well
document
clinic
signific
risk
liver
diseas
vertic
transmiss
hcv
still
unknown
time
hcv
infect
vertic
transmiss
also
unknown
utero
transmiss
suggest
studi
wherea
intrapartum
postpartum
transmiss
propos
ohto
et
al
document
absenc
hcv
rna
cord
blood
neonat
later
becam
hcv
rna
posit
month
age
recent
gibb
et
al
report
two
piec
data
support
likelihood
intrapartum
transmiss
predomin
time
vertic
transmiss
low
sensit
pcr
hcv
rna
test
first
month
life
mark
increas
sensit
diagnos
hcv
infect
infant
b
lower
transmiss
risk
elect
cesarean
deliveri
without
prolong
ruptur
membran
compar
vagin
emerg
cesarean
deliveri
anoth
group
mcmenamin
et
al
analyz
vertic
transmiss
motherinf
pair
overal
vertic
transmiss
rate
anoth
infant
test
lost
followup
comparison
vertic
transmiss
rate
differ
vagin
deliveri
emerg
cesarean
labor
versu
plan
cesarean
vs
held
true
even
mother
hepat
c
rna
detect
antenat
vs
author
support
plan
cesarean
deliveri
decreas
vertic
transmiss
hepat
c
infect
prospect
control
trial
cesarean
versu
vagin
deliveri
occurr
vertic
hepat
c
transmiss
avail
risk
hcv
transmiss
via
breast
milk
uncertain
antihcv
antibodi
hcv
rna
demonstr
colostrum
breast
milk
although
level
hcv
rna
milk
correl
titer
hcv
rna
serum
nevertheless
transmiss
hcv
via
breastfeed
utero
intrapartum
postpartum
sourc
proven
small
number
infant
studi
transmiss
rate
breastf
nonbreastf
infant
appear
similar
variou
import
factor
control
hcv
rna
titer
mother
examin
milk
hcv
rna
exclus
breastfeed
versu
exclus
formula
feed
versu
partial
breastfeed
durat
breastfeed
zanetti
et
al
includ
infant
whose
mother
seroposit
hcv
rna
eight
infant
studi
infect
hcv
mother
hiv
hcv
three
eight
infant
infect
hiv
hcv
hcv
rna
level
significantli
higher
mother
coinfect
hiv
compar
mother
hcv
alon
overal
risk
hcv
infect
via
breastfeed
low
risk
hcv
infect
appear
frequent
associ
hiv
infect
higher
level
hcv
rna
matern
serum
effect
prevent
therapi
ig
vaccin
exist
risk
chronic
hcv
infect
subsequ
sequela
infect
high
therefor
appropri
discuss
theoret
risk
breastfeed
hcvposit
mother
mother
parent
consid
proscrib
breast
milk
appropri
altern
sourc
nutrit
avail
infant
hiv
infect
separ
contraind
breastfeed
addit
studi
necessari
determin
exact
role
breastfeed
transmiss
hcv
includ
quantit
measur
hcv
rna
colostrum
breast
milk
rel
risk
hcv
transmiss
exclus
partial
breastf
infant
versu
risk
formulaf
infant
effect
durat
breastfeed
transmiss
current
posit
cdc
data
indic
hcv
viru
transmit
breast
milk
therefor
breastfeed
hcvposit
hivneg
mother
contraind
infant
born
hcv
rnaposit
mother
requir
followup
month
age
determin
infant
hcv
statu
regardless
mode
infant
feed
infant
test
alanin
aminotransferas
hcv
rna
month
month
age
alanin
aminotransferas
antihcv
antibodi
test
month
age
confirm
infant
statu
uninfect
ongo
hepat
c
infect
past
hcv
infect
hepat
viru
hdv
defect
rna
viru
caus
hepat
person
also
infect
hbv
infect
occur
either
acut
coinfect
hbv
hdv
superinfect
hbv
carrier
doubl
infect
result
frequent
fulmin
hepat
chronic
hepat
progress
cirrhosi
viru
use
hbv
rna
circular
negativestrand
rna
antigen
hdag
surround
surfac
antigen
hbv
hbsag
hdv
transmit
way
hbv
especi
exchang
blood
bodi
fluid
hdv
infect
uncommon
preval
hbv
low
area
hbv
endem
preval
hdv
highli
variabl
hdv
common
tropic
africa
south
america
well
greec
itali
uncommon
far
east
alaskan
inuit
despit
endem
occurr
hbv
area
transmiss
hdv
report
occur
household
contact
rare
vertic
transmiss
data
avail
transmiss
hdv
breastfeed
hdv
infect
prevent
block
infect
hbv
therefor
hbig
hbv
vaccin
best
protect
addit
hbig
hbv
vaccin
administr
infant
mother
infect
hbv
hdv
discuss
mother
parent
includ
theoret
risk
hbv
hdv
transmiss
breastfeed
hbv
hbig
hbv
vaccin
given
infant
risk
hbv
hdv
infect
breastfeed
neglig
therefor
breastfeed
inform
discuss
parent
accept
hepat
e
viru
hev
caus
sporad
epidem
enter
transmit
nanbh
typic
selflimit
without
chronic
sequela
hev
notabl
caus
high
mortal
rate
pregnant
women
transmiss
primarili
via
fecalor
rout
commonli
via
contamin
water
food
high
infect
rate
report
adolesc
young
adult
age
year
tomar
report
case
hev
infect
pediatr
popul
india
manifest
acut
hepat
maternalneonat
transmiss
document
mother
develop
hepat
e
infect
third
trimest
although
hev
demonstr
breast
milk
transmiss
via
breast
milk
confirm
report
five
case
transfusionassoci
hepat
e
report
epidem
usual
relat
contamin
water
persontoperson
spread
minim
even
household
day
care
set
although
ig
may
protect
control
trial
done
anim
studi
suggest
recombin
subunit
vaccin
may
feasibl
hev
infect
infanc
rare
data
exist
transmiss
hev
breastfeed
evid
clinic
signific
postnat
hev
infect
infant
chronic
sequela
associ
hev
infect
document
hev
transmiss
breast
milk
avail
current
contraind
exist
breastfeed
matern
hev
infect
ig
shown
effect
prevent
infect
vaccin
avail
hev
hepat
g
viru
hgv
recent
confirm
caus
nanbh
distinct
hepat
virus
e
sever
close
relat
genom
hgv
current
name
gbva
b
c
appear
relat
hcv
pestivirus
flavivirus
epidemiolog
hgv
often
associ
transfus
blood
although
studi
identifi
nontransfusionrel
case
hgv
genom
rna
detect
patient
acut
chronic
hepat
small
number
patient
fulmin
hepat
gbvchgv
also
found
patient
inflammatori
bile
duct
lesion
pathogen
viru
unconfirm
hgv
rna
detect
healthi
blood
donor
unit
state
feucht
et
al
describ
maternaltoinf
transmiss
hgv
three
nine
children
two
three
mother
coinfect
hiv
third
hcv
none
infant
develop
sign
liver
diseas
neither
time
mode
transmiss
clarifi
lin
et
al
report
hgv
transmiss
three
motherinf
pair
cesarean
deliveri
discuss
transplacent
spread
via
blood
like
mode
hgv
infect
vertic
transmiss
wejstal
et
al
report
perinat
transmiss
hgv
infant
born
hgv
virem
mother
identifi
pcr
hgv
appear
caus
hepat
children
fischler
et
al
follow
eight
children
born
hgvposit
mother
found
one
infect
hgv
child
remain
clinic
well
twin
also
born
cesarean
deliveri
breastf
remain
hgv
neg
year
observ
five
six
children
breastf
variabl
period
without
evid
hgv
infect
ohto
et
al
examin
hgv
mothertoinf
transmiss
pregnant
japanes
women
screen
identifi
posit
gbvchgv
rna
pcr
infant
born
hgv
posit
women
shown
hgv
rna
posit
reportedli
none
infant
demonstr
clinic
pictur
hepat
although
two
infant
persist
mild
elev
less
two
time
normal
alanin
aminotransferas
viral
load
mother
transmit
hgv
infant
significantli
higher
nontransmit
mother
infant
born
elect
cesarean
deliveri
lower
rate
infect
compar
infant
born
emerg
cesarean
deliveri
born
vagin
studi
hgv
infect
breastf
infant
four
time
common
formulaf
infant
differ
statist
signific
four
infant
formula
fed
author
report
correl
infect
rate
durat
breastfeed
seen
test
infant
done
frequent
earli
enough
routin
first
year
life
determin
time
infect
infant
et
al
report
transmiss
hgv
infant
born
hgv
rna
posit
mother
week
age
none
breast
milk
sampl
posit
gbvchgv
rna
children
initi
neg
hgv
rna
serum
remain
neg
followup
month
age
forego
data
suggest
transmiss
like
vertic
deliveri
rather
via
breastfeed
pathogen
possibl
chronic
diseas
due
hgv
infect
remain
uncertain
time
insuffici
data
avail
make
recommend
concern
breastfeed
hgvinfect
mother
herp
simplex
viru
type
caus
prenat
perinat
postnat
infect
fetus
infant
prenat
infect
lead
abort
prematur
recogn
congenit
syndrom
perinat
infect
common
form
infect
live
birth
case
per
year
unit
state
often
fatal
sever
debilit
factor
facilit
intrapartum
infect
predict
sever
diseas
extens
investig
postnat
infect
uncommon
occur
varieti
sourc
includ
oral
genit
lesion
secret
mother
father
hospit
worker
home
caregiv
breast
lesion
breastfeed
mother
number
case
report
document
sever
infect
infant
associ
hsvposit
breast
lesion
mother
case
infant
hsv
gingivostomat
inocul
mother
breast
also
report
absenc
breast
lesion
breastfeed
hsvseroposit
cultureposit
women
reason
accompani
care
handwash
cover
lesion
avoid
fondl
kiss
oral
lesion
lesion
crust
breastfeed
matern
therapi
oral
iv
acyclovir
continu
safe
well
inadequ
inform
exist
concern
valacyclovir
famciclovir
ganciclovir
foscarnet
breast
milk
make
recommend
time
breastfeed
women
activ
herpet
lesion
breast
proscrib
lesion
dri
treatment
mother
breast
lesion
topic
oral
andor
iv
antivir
prepar
may
hasten
recoveri
decreas
length
viral
shed
human
herpesviru
caus
exanthema
subitum
roseola
roseola
infantum
associ
febril
seizur
appear
similar
cmv
base
genet
analysi
obviou
congenit
syndrom
infect
identifi
although
prenat
infect
report
seroepidemiolog
studi
show
adult
alreadi
infect
therefor
primari
infect
pregnanc
unlik
reactiv
latent
infect
may
common
case
symptomat
prenat
infect
report
signific
reactiv
pregnant
woman
product
infect
diseas
fetu
infant
remain
determin
primari
infect
children
occur
often
month
age
matern
acquir
passiv
antibodi
wane
febril
ill
infant
younger
month
age
describ
infect
infect
month
year
uncommon
variou
studi
involv
serolog
restrict
enzym
analysi
isol
motherinf
pair
support
idea
postnat
transmiss
perhap
perinat
transmiss
mother
common
sourc
infect
one
studi
unabl
detect
breast
milk
pcr
analysi
sampl
although
posit
control
sampl
seed
cell
test
posit
given
limit
occurr
clinic
signific
diseas
absenc
sequela
infect
infant
children
almost
univers
acquisit
infect
earli
childhood
without
breastfeed
absenc
evid
breast
milk
sourc
infect
breastfeed
continu
women
known
seroposit
human
herpesviru
close
relat
biolog
primari
infect
occur
primarili
childhood
usual
later
life
infect
median
age
infect
month
children
becom
posit
year
age
seropreval
antibodi
report
adult
passiv
antibodi
present
almost
newborn
like
infect
associ
acut
febril
ill
febril
seizur
irrit
gener
milder
ill
fewer
hospit
viru
excret
occur
saliva
pcr
test
blood
cell
saliva
frequent
posit
individu
past
infect
congenit
infect
detect
via
dna
pcr
test
cord
blood
sampl
detect
cord
blood
specimen
dna
detect
pcr
breast
milk
mononuclear
cell
sampl
women
serum
posit
antibodi
studi
small
differ
seen
seroposit
rate
breastf
infant
bottlef
infant
month
age
versu
month
age
versu
month
age
versu
respect
none
differ
statist
signific
given
gener
infect
occur
earlier
infect
infant
rare
found
breast
milk
seem
unlik
breast
milk
common
sourc
infect
infant
children
infrequ
occurr
signific
ill
infect
absenc
sequela
except
patient
transplant
surgeri
older
age
common
occurr
infect
childhood
argu
reason
proscrib
breastfeed
posit
women
exist
human
papillomaviru
hpv
dna
viru
least
differ
type
virus
caus
wart
genit
dysplasia
cervic
carcinoma
type
laryng
papillomatosi
transmiss
occur
direct
contact
sexual
contact
laryng
papilloma
thought
result
acquir
viru
passag
birth
canal
infect
pregnant
women
pregnanc
lead
increas
abort
risk
prematur
evid
indic
intrauterin
infect
hpv
one
common
virus
adult
one
commonli
sexual
transmit
infect
diagnosi
usual
histolog
examin
dna
detect
spontan
resolut
occur
therapi
persist
lesion
growth
anatom
problemat
locat
appropri
therapi
podophyllum
prepar
trichloroacet
acid
cryotherapi
electrocauteri
laser
surgeri
interferon
test
treatment
laryng
papilloma
mix
result
prevent
transmiss
mean
limit
direct
sexual
contact
may
suffici
lesion
may
evid
transmiss
may
still
occur
rintala
et
al
examin
occurr
hpv
dna
oral
genit
mucosa
infant
first
year
life
hpv
dna
identifi
oral
scrape
sampl
genit
scrape
sampl
pcr
oral
hpv
infect
acquir
children
clear
persist
children
children
never
infect
report
breast
milk
breastfeed
studi
question
sourc
infect
remain
undetermin
breast
rare
site
involv
hpv
type
immort
normal
breast
epithelium
vitro
hpv
dna
detect
breast
milk
milk
sampl
mother
collect
day
postpartum
attempt
made
correl
presenc
hpv
dna
breast
milk
hpv
statu
infant
assess
viral
load
hpv
breast
milk
presenc
cours
lactat
second
studi
found
dna
cutan
mucos
hpv
type
human
milk
sampl
colostrum
sampl
report
hpv
lesion
breast
nippl
document
transmiss
infant
secondari
breastfeed
avail
increas
risk
acquir
hpv
breast
milk
appar
breastfeed
accept
even
rare
occurr
hpv
lesion
nippl
breast
data
suggest
breastfeed
use
express
breast
milk
contraind
measl
anoth
highli
communic
childhood
ill
sever
neonat
adult
measl
exanthemat
febril
ill
follow
prodrom
malais
coryza
conjunct
cough
often
koplik
spot
mouth
rash
usual
appear
day
exposur
complic
includ
pneumon
enceph
bacteri
superinfect
avail
vaccin
measl
pregnanc
rare
pregnanc
although
respiratori
complic
primari
viral
pneumon
secondari
bacteri
pneumonia
hepat
secondari
bacteri
infect
often
lead
sever
diseas
situat
prenat
infect
measl
may
caus
prematur
deliveri
without
disrupt
normal
uterin
develop
specif
group
congenit
malform
describ
associ
utero
measl
infect
although
teratogen
effect
measl
infect
pregnant
women
may
rare
manifest
infant
perinat
measl
includ
transplacent
infect
measl
occur
infant
first
day
life
infect
extrauterin
exposur
usual
develop
day
life
sever
ill
suspect
transplacent
spread
viru
infant
vari
mild
sever
seem
vari
antepartum
postpartum
onset
rash
mother
uncertain
role
matern
antibodi
play
sever
infant
diseas
sever
diseas
seem
associ
sever
respiratori
ill
bacteri
infect
postnat
exposur
lead
measl
day
life
gener
mild
probabl
passiv
acquir
antibodi
mother
sever
measl
children
younger
year
age
may
occur
declin
passiv
acquir
antibodi
complic
respiratori
ill
rare
case
enceph
measl
viru
identifi
breast
milk
wherea
measlesspecif
antibodi
document
infant
expos
mother
document
measl
breastfeed
given
immunoglobulin
ig
isol
mother
hour
onset
rash
often
short
period
diagnosi
measl
mother
breast
milk
pump
given
infant
secretori
iga
begin
secret
breast
milk
within
hour
onset
exanthem
mother
tabl
summar
manag
hospit
mother
infant
measl
exposur
infect
mump
acut
transient
benign
ill
inflamm
parotid
gland
salivari
gland
often
involv
pancrea
testicl
mening
mump
occur
infrequ
pregnant
women
case
pregnanc
gener
benign
mump
viru
isol
saliva
respiratori
secret
blood
testicular
tissu
urin
csf
case
mening
involv
breast
milk
period
infect
believ
day
day
onset
parot
usual
incub
period
day
prenat
infect
mump
viru
caus
increas
number
abort
infect
occur
first
trimest
small
increas
number
prematur
birth
note
one
prospect
studi
matern
mump
infect
conclus
evid
suggest
congenit
malform
associ
prenat
infect
even
endocardi
fibroelastosi
origin
report
perinat
mump
transplacent
postnat
acquir
rare
ever
document
natur
mump
viru
demonstr
infect
placenta
infect
fetu
live
attenu
vaccin
viru
isol
placenta
fetal
tissu
women
vaccin
day
induc
abort
antibodi
mump
cross
placenta
postnat
mump
first
year
life
typic
benign
epidemiolog
data
suggest
mump
infect
less
common
sever
breastf
infant
compar
formulaf
infant
although
mump
viru
identifi
breast
milk
mastiti
rare
complic
mump
matur
women
evid
indic
breast
involv
occur
frequent
lactat
women
mump
occur
mother
breastfeed
continu
exposur
alreadi
occur
throughout
day
develop
symptom
mother
secretori
iga
milk
may
help
mitig
symptom
infant
human
parvoviru
caus
broad
rang
clinic
manifest
includ
asymptomat
infect
frequent
manifest
age
erythema
infectiosum
fifth
diseas
arthralgia
arthriti
red
blood
cell
rbc
aplasia
less
often
decreas
white
blood
cell
platelet
chronic
infect
immunodefici
individu
rare
myocard
vascul
hemophagocyt
syndrom
vertic
transmiss
lead
sever
anemia
immunemedi
hydrop
fetali
treat
accur
diagnos
intrauterin
transfus
inflamm
liver
cn
seen
infant
along
vascul
child
clinic
well
birth
hidden
persist
abnorm
rare
identifi
evid
indic
parvoviru
caus
identifi
pattern
birth
defect
postnat
transmiss
usual
occur
person
person
via
contact
respiratori
secret
saliva
rare
blood
urin
seropreval
children
year
age
less
peak
age
infect
occur
schoolag
year
children
infect
major
infect
asymptomat
undiagnos
seroconvers
sever
diseas
prolong
aplast
anemia
occur
individu
hemoglobinopathi
abnorm
rbc
matur
attack
rate
estim
casual
contact
among
household
contact
one
studi
suscept
pregnant
women
annual
seroconvers
rate
report
transmiss
infant
breastfeed
avail
excret
breast
milk
studi
limit
cultur
techniqu
rat
parvoviru
demonstr
rat
milk
low
seroconvers
rate
young
children
absenc
chronic
frequent
sever
diseas
suggest
risk
parvoviru
infect
via
breast
milk
signific
possibl
antibodi
parvoviru
protect
constitu
breast
milk
studi
breastfeed
mother
parvoviru
infect
accept
polioviru
infect
type
caus
rang
ill
subclin
abort
manifest
paralyt
poliomyel
review
bate
case
poliomyel
infant
younger
month
age
demonstr
paralysi
death
one
child
without
evid
even
transient
paralysi
half
case
ascrib
transmiss
mother
although
mention
made
breastfeed
breastfeed
rate
time
approxim
prenat
infect
poliovirus
caus
increas
incid
abort
prematur
stillbirth
appar
occur
frequent
mother
develop
paralyt
diseas
versu
inappar
infect
although
individu
report
congenit
malform
associ
matern
poliomyel
exist
epidemiolog
data
suggest
poliovirus
teratogen
also
evid
indic
live
attenu
vaccin
polioviru
given
pregnanc
associ
congenit
malform
perinat
infect
note
sever
case
report
infant
infect
utero
sever
day
birth
sever
diseas
manifest
neurolog
manifest
paralysi
without
fever
irrit
vomit
addit
case
report
infect
acquir
postnat
demonstr
ill
consist
poliomyel
childhood
case
sever
involv
paralysi
may
repres
report
bia
data
avail
concern
presenc
polioviru
breast
milk
although
antibodi
polioviru
type
document
era
increas
worldwid
polioviru
vaccin
likelihood
prenat
perinat
polioviru
infect
decreas
matern
suscept
polioviru
determin
concept
polioviru
vaccin
offer
suscept
women
analysi
last
great
epidem
itali
done
use
populationbas
casecontrol
studi
birth
infant
report
paralyt
poliomyel
group
match
control
subject
select
infant
admit
hospit
time
use
dichotom
variabl
never
breastf
partial
breastf
neverbreastf
infant
among
case
among
control
group
author
determin
odd
ratio
confid
interv
demonstr
risk
paralyt
poliomyel
higher
infant
never
breastf
lowest
among
exclus
breastf
time
diagnosi
poliomyel
made
breastfeed
mother
exposur
infant
polioviru
matern
secret
alreadi
occur
breast
milk
alreadi
contain
antibodi
may
protect
reason
exist
interrupt
breastfeed
breastfeed
also
interfer
success
immun
poliomyel
oral
inactiv
polioviru
vaccin
occurr
human
tcell
leukemia
viru
type
htlvi
endem
part
southwestern
japan
caribbean
south
america
subsaharan
africa
htlvi
associ
adult
tcell
leukemialymphoma
chronic
condit
progress
neuropathi
progress
neuropathi
call
htlvi
associ
myelopathi
tropic
spastic
paraparesi
ill
report
associ
htlvi
infect
includ
dermat
uveiti
arthriti
syndrom
adult
infect
dermat
persist
lymphaden
children
transmiss
htlvi
occur
often
sexual
contact
via
blood
blood
product
via
breast
milk
infrequ
transmiss
occur
utero
deliveri
casual
household
contact
seropreval
gener
increas
age
vari
wide
differ
region
popul
differ
background
area
japan
seroposit
high
south
america
africa
caribbean
countri
rate
latin
america
seroposit
rate
high
among
femal
sex
worker
attende
std
clinic
blood
donor
europ
seropreval
htlvi
report
seropreval
pregnant
women
endem
area
japan
high
nonendem
area
low
major
diseas
unit
state
studi
europ
seropreval
pregnant
women
note
pregnant
women
primarili
african
caribbean
descent
htlvi
antigen
identifi
breast
milk
htlvi
posit
mother
anoth
report
show
basal
mammari
epitheli
cell
infect
htlvi
transfer
infect
peripher
blood
monocyt
human
milk
htlvi
posit
mother
caus
infect
marmoset
htlvi
infect
clearli
occur
via
breastfeed
number
report
document
increas
rate
transmiss
htlvi
breastf
infant
compar
formulaf
infant
ando
et
al
two
separ
report
demonstr
parallel
declin
antibodi
htlvi
formulaf
breastf
infant
nadir
approxim
year
age
subsequ
increas
antibodi
year
age
percentag
children
seroposit
year
age
breastf
formulaf
group
respect
year
age
year
age
smaller
group
children
follow
year
age
demonstr
newli
infect
children
year
age
refer
loss
antibodi
child
seroposit
year
age
transmiss
htlvi
infect
via
breastfeed
also
clearli
associ
durat
breastfeed
postul
persist
passiv
acquir
antibodi
htlvi
offer
protect
month
life
tabl
factor
relat
htlvi
transmiss
via
breast
milk
propos
yoshinaga
et
al
present
data
htlvi
antigen
produc
capac
peripher
blood
breast
milk
cell
show
increas
mothertochild
transmiss
rate
mother
blood
breast
milk
produc
larg
number
antigenproduc
cell
cultur
hisada
et
al
report
mother
infant
jamaica
demonstr
higher
matern
proviru
level
higher
htlvi
antibodi
titer
independ
associ
htlvi
transmiss
infant
uretavid
et
al
report
increas
seroposit
rate
children
mother
high
provir
load
elev
matern
htlvi
antibodi
titer
variou
intervent
propos
decreas
htlvi
transmiss
via
breastfeed
complet
avoid
breastfeed
shown
effect
intervent
hino
et
al
larg
popul
japanes
nagasaki
avoid
breastfeed
led
decreas
transmiss
breastfeed
shorter
durat
anoth
effect
altern
ando
et
al
show
freez
thaw
breast
milk
decreas
infect
htlvi
sawada
et
al
demonstr
rabbit
model
htlvi
immunoglobulin
protect
htlvi
transmiss
via
milk
reason
postul
measur
would
decreas
matern
proviru
load
increas
antihtlvi
antibodi
avail
infant
might
decreas
risk
transmiss
overal
preval
htlvi
infect
childhood
unknown
major
individu
manifest
ill
much
later
life
time
htlvi
infect
breastfeed
popul
difficult
assess
passiv
acquir
antibodi
mother
issu
relat
test
furnia
et
al
area
preval
htlvi
infect
unit
state
canada
europ
rare
likelihood
singl
test
antibodi
htlvi
would
fals
posit
test
high
compar
number
true
posit
test
repeat
test
warrant
mani
situat
quantif
antibodi
titer
provir
load
appropri
situat
mothertochild
transmiss
concern
greater
risk
progress
diseas
later
life
shown
htlvi
infect
breast
milk
earlylif
infect
associ
greatest
risk
adult
tcell
leukemia
mother
famili
inform
issu
risk
lack
breast
milk
great
formula
readili
avail
cultur
accept
proscript
breastfeed
least
recommend
limit
durat
breastfeed
month
less
appropri
limit
risk
htlvi
transmiss
infant
freez
thaw
breast
milk
give
infant
might
anoth
reason
intervent
decreas
risk
transmiss
although
control
trial
document
efficaci
intervent
neither
ig
antivir
agent
htlvi
avail
time
human
tcell
leukemia
viru
type
ii
htlvii
endem
specif
geograph
locat
includ
africa
america
caribbean
japan
transmiss
primarili
intraven
drug
use
contamin
blood
product
breastfeed
sexual
transmiss
occur
overal
contribut
preval
htlvii
differ
popul
remain
uncertain
mani
studi
examin
presenc
htlvi
ii
blood
product
pcr
test
select
antibodi
test
suggest
half
htlv
seroposit
blood
donor
caus
htlvii
htlvii
associ
two
chronic
neurolog
disord
similar
caus
htlvi
tropic
spastic
ataxia
connect
htlvii
glomerulonephr
myelopathi
arthriti
thairi
cell
leukemia
larg
granulocyt
leukemia
report
mothertochild
transmiss
demonstr
breastf
formulaf
infant
appear
rate
transmiss
greater
breastf
infant
htlvii
detect
breast
milk
nyambi
et
al
report
htlvii
transmiss
correl
durat
breastfeed
estim
rate
transmiss
time
seroconvers
initi
loss
passiv
acquir
matern
antibodi
infect
infant
seem
rang
year
age
time
avoid
breastfeed
limit
durat
breastfeed
two
possibl
intervent
evid
effect
prevent
htlvii
mothertochild
transmiss
current
understand
retrovirus
appropri
case
document
htlvii
matern
infect
recommend
avoid
limit
durat
breastfeed
provid
altern
nutrit
financi
practic
cultur
accept
mother
confirmatori
test
htlvii
measur
provir
load
infant
serial
test
antibodi
htlvii
confirmatori
test
seroposit
month
age
investig
mechan
transmiss
via
breast
milk
possibl
intervent
prevent
transmiss
occur
htlvi
human
immunodefici
viru
type
transmit
human
milk
refrain
breastfeed
crucial
aspect
prevent
perinat
hiv
infect
unit
state
mani
countri
dilemma
use
replac
feed
versu
breastfeed
countri
breastfeed
provid
infant
signific
protect
ill
death
due
malnutrit
infect
question
contribut
breastfeed
mothertochild
transmiss
trivial
one
one
consid
follow
estim
million
peopl
newli
infect
children
younger
year
old
make
million
number
declin
due
increas
access
intervent
prevent
mothertoinf
transmiss
avail
antiretrovir
therapi
prevent
mothertochild
hiv
transmiss
develop
countri
estim
reach
mother
need
breastfeed
contribut
estim
increas
overal
mothertochild
transmiss
rate
intrauterin
intrapartum
transmiss
specif
intervent
prevent
transmiss
via
breastfeed
util
despit
dramat
increas
number
peopl
receiv
antiretrovir
therapi
develop
countri
million
repres
individu
need
treatment
evid
hiv
transmiss
via
breastfeed
irrefut
multipl
public
summar
current
evid
hiv
transmiss
via
breastfeed
literatur
sinc
case
report
document
hiv
transmiss
via
breast
milk
children
around
world
primari
hiv
infect
breastfeed
mother
concomit
high
viral
load
associ
particularli
high
rate
hiv
transmiss
via
breast
milk
palasanthiran
et
al
estim
risk
larg
observ
studi
demonstr
higher
rate
hiv
transmiss
breastf
infant
mother
chronic
hiv
infect
compar
formulaf
infant
systemat
analysi
publish
report
estim
addit
risk
perinat
hiv
transmiss
due
breastfeed
confid
interv
recent
publish
cohort
studi
similarli
attribut
addit
risk
hiv
transmiss
due
breastfeed
risk
prenat
intrapartum
transmiss
laboratori
report
demonstr
presenc
cellfre
viru
cellassoci
viru
breast
milk
well
variou
immunolog
factor
could
block
limit
infect
doserespons
relationship
observ
correl
hiv
viral
load
human
milk
well
mother
plasma
viral
load
increas
transmiss
risk
breastf
infant
mani
potenti
risk
factor
associ
human
milk
transmiss
hiv
higher
longer
durat
breastfeed
matern
characterist
relat
transmiss
hiv
via
human
milk
includ
younger
matern
age
higher
pariti
lower
count
higher
plasma
viral
load
breast
abnorm
mastiti
abscess
nippl
lesion
characterist
human
milk
relat
higher
risk
transmiss
includ
higher
viral
load
milk
lower
concentr
antivir
substanc
lactoferrin
lysozym
lower
concentr
virusspecif
cytotox
tlymphocyt
level
variou
interleukin
secretori
iga
igm
mix
breastfeed
also
associ
higher
risk
hiv
transmiss
compar
exclus
breastfeed
measur
benefit
breast
milk
versu
rel
risk
hiv
transmiss
infant
due
exclus
breastfeed
optim
factor
decreas
hiv
transmiss
report
coupl
studi
measur
benefit
receiv
breast
milk
versu
rel
increas
risk
hiv
transmiss
need
determin
prospect
fashion
differ
local
number
potenti
intervent
prevent
breastfeed
transmiss
util
box
simplest
effect
compet
avoid
human
milk
practic
solut
place
like
unit
state
countri
replac
feed
well
strictli
medic
intervent
feasibl
reason
risk
provid
breast
milk
infant
neglig
resourcepoor
situat
risk
infect
high
without
benefit
breast
milk
exclus
breastfeed
appropri
reason
cultur
accept
intervent
decreas
hiv
transmiss
via
breast
milk
potenti
effect
intervent
includ
exclus
breastfeed
earli
wean
versu
breastfeed
longer
durat
educ
support
decreas
likelihood
mastiti
nippl
lesion
possibl
intervent
includ
treat
mother
antiretrovir
therapi
health
count
less
prophylact
decreas
human
milk
viral
load
treat
infant
prophylact
prolong
period
time
week
month
protect
transmiss
via
breastfeed
treat
milk
decreas
viral
load
pasteur
method
treat
acut
condit
mother
infant
eg
mastiti
breast
lesion
infant
candidiasi
enhanc
infant
defens
via
vitamin
immun
antiretrovir
therapi
may
feasibl
certain
set
pasteur
matern
antiretrovir
therapi
other
may
cultur
accept
treat
express
breast
milk
give
infant
even
exclus
breastfeed
signific
data
demonstr
advantag
breastfeed
even
hivinfect
hivexpos
infant
complet
avoid
breastfeed
certain
situat
may
lead
increas
risk
ill
death
due
reason
besid
hiv
transmiss
studi
kenya
show
improv
surviv
rate
formulaf
group
children
born
hivposit
mother
breastf
formula
group
similar
mortal
rate
versu
respect
similar
incid
diarrhea
pneumonia
first
year
life
differ
two
group
seen
preval
malnutrit
breastf
infant
better
nutrit
statu
first
month
life
arpadi
et
al
recommend
addit
nutrit
intervent
complement
breastfeed
popul
month
age
two
report
zambia
document
benefit
exclus
breastfeed
decreas
late
hiv
transmiss
lower
mortal
month
infant
continu
breastfeed
rather
discontinu
breastfeed
month
age
malawi
hivinfect
hivexpos
infant
breastf
exclus
breastfeed
month
mix
feed
lower
mortal
month
breastf
report
botswana
examin
breastfeed
plu
infant
zidovudin
prophylaxi
month
versu
formula
feed
plu
infant
zidovudin
month
studi
show
decreas
risk
vertic
transmiss
formula
feed
also
increas
cumul
mortal
hivinfect
infant
month
age
formulaf
group
studi
south
africa
examin
use
vitamin
also
demonstr
less
morbid
hivinfect
children
breastf
breastf
abstract
report
shown
increas
morbid
hivinfect
children
due
diarrhea
gastroenter
hospit
wean
breastfeed
exclus
breastfeed
area
world
essenti
infant
health
surviv
even
situat
matern
hiv
infect
durat
exclus
breastfeed
crucial
decreas
risk
hiv
infect
infant
versu
risk
malnutrit
infect
earli
wean
mashi
studi
botswana
thior
et
al
evalu
infant
random
breastfeed
plu
infant
zidovudin
month
formula
feed
plu
month
infant
zidovudin
cumul
infant
mortal
significantli
higher
month
formulaf
group
month
similar
two
group
breastf
infant
like
becom
hiv
infect
despit
month
zidovudin
prophylaxi
becquet
et
al
analyz
data
cote
divoir
hivexpos
infant
breastf
median
month
formula
fed
observ
year
signific
differ
rate
hiv
infect
seen
two
group
signific
differ
two
group
seen
morbid
event
diarrhea
acut
respiratori
infect
malnutrit
hospit
death
author
attribut
good
outcom
effect
nutrit
counsel
care
access
clean
water
provis
safe
continu
suppli
breast
milk
substitut
coovadia
et
al
studi
exclus
breastfeed
first
month
life
intervent
south
africa
exclus
breastf
infant
week
age
month
age
hiv
infect
breastf
infant
also
fed
solid
formula
milk
like
acquir
infect
exclus
breastf
infant
cumul
mortal
month
age
markedli
lower
exclus
breastf
infant
versu
infant
receiv
mix
feed
kuhn
et
al
examin
effect
earli
abrupt
wean
hivfre
surviv
children
zambia
infant
randomli
assign
two
differ
counsel
program
advis
either
abrupt
wean
month
prolong
breastfeed
wean
intervent
group
mother
stop
breastfeed
month
compar
median
durat
breastfeed
month
control
group
studi
found
signific
differ
hivfre
surviv
women
health
care
provid
need
awar
potenti
risk
transmiss
hiv
infect
infant
pregnanc
peripartum
period
breast
milk
document
routin
hiv
educ
routin
test
consent
women
seek
prenat
care
strongli
recommend
woman
know
hiv
statu
method
avail
prevent
acquisit
transmiss
hiv
determin
whether
breastfeed
appropri
deliveri
educ
hiv
test
consent
women
whose
hiv
statu
pregnanc
unknown
strongli
recommend
knowledg
woman
hiv
statu
assist
counsel
breastfeed
help
woman
understand
benefit
infant
know
serostatu
behavior
would
decreas
likelihood
acquisit
transmiss
hiv
women
known
hiv
infect
must
counsel
breastfe
provid
milk
nutrit
infant
gener
women
known
hiv
seroneg
encourag
breastfe
howev
women
hiv
seroneg
particularli
high
risk
seroconvers
eg
inject
drug
user
sexual
partner
known
hivposit
person
activ
drug
user
educ
hiv
individu
recommend
concern
appropri
breastfeed
addit
perinat
period
inform
provid
potenti
risk
transmit
hiv
breast
milk
method
reduc
risk
acquir
hiv
infect
woman
whose
hiv
statu
unknown
inform
potenti
hivinfect
women
transmit
hiv
peripartum
period
breast
milk
potenti
benefit
infant
know
hiv
statu
hiv
acquir
transmit
health
care
provid
need
make
individu
recommend
assist
woman
decid
whether
breastfe
month
two
group
versu
children
alreadi
infect
month
age
higher
mortal
assign
earli
wean
group
versu
addit
analysi
show
mother
less
sever
hiv
diseas
earli
wean
clearli
harm
infant
arpadi
et
al
studi
growth
hivexpos
uninfect
children
exclus
breastf
month
rapid
wean
replac
food
exclus
breastf
month
continu
breastfeed
complementari
food
weightforag
z
score
drop
markedli
group
month
age
less
continu
breastfeed
group
lengthforag
z
score
also
drop
dramat
influenc
continu
breastfeed
even
hivexpos
uninfect
group
children
addit
nutrit
intervent
essenti
complement
breastfeed
beyond
month
age
recent
year
discuss
around
prevent
hiv
transmiss
via
breastfeed
number
studi
examin
import
issu
increas
fact
intrapartum
perinat
transmiss
hiv
mother
infant
decreas
markedli
due
increas
util
antiretrovir
therapi
pregnanc
deliveri
postnat
prevent
emphas
import
work
harder
decreas
breast
milk
transmiss
hiv
consid
differ
possibl
intervent
decreas
motherinf
hiv
transmiss
crucial
reemphas
goal
optim
matern
health
surviv
optim
infant
health
surviv
time
laboratori
report
show
mother
receiv
highli
activ
antiretrovir
therapi
haart
breastfeed
decreas
whole
breast
milk
viral
load
mother
less
copiesml
compar
mother
receiv
haart
less
copiesml
howev
whole
milk
dna
load
measur
undetect
less
cell
significantli
differ
haart
mother
nonhaart
group
dna
incorpor
cell
found
breast
milk
anoth
group
show
significantli
lower
hiv
rna
level
breast
milk
women
treat
nevirapin
zidovudin
lamivudin
compar
women
receiv
antiretrovir
therapi
use
matern
haart
seem
decreas
transmiss
via
breastfeed
one
group
work
mozambiqu
malawi
tanzania
work
motherinf
pair
receiv
haart
prevent
pregnanc
compar
one
cohort
motherinf
pair
receiv
supplementari
formula
water
filter
first
month
life
second
cohort
motherinf
pair
breastfeed
exclus
mother
receiv
haart
first
month
cumul
incid
rate
hiv
infect
month
age
formulaf
infant
breastf
infant
month
age
appar
addit
risk
late
postnat
transmiss
hiv
observ
petra
studi
team
work
tanzania
south
africa
uganda
examin
efficaci
three
shortcours
regimen
zidovudin
lamivudin
prevent
earli
late
hiv
transmiss
predominantli
breastfeed
popul
four
regimen
zidovudin
lamivudin
start
week
gestat
plu
intrapartum
medic
postpartum
treatment
b
without
prepartum
compon
c
intrapartum
zidovudin
lamivudin
placebo
week
hiv
transmiss
rate
group
group
b
group
c
group
month
hiv
infect
rate
group
group
b
group
c
group
although
measur
decreas
transmiss
week
age
observ
limit
protect
seen
month
age
observ
studi
tanzania
compar
matern
haart
month
exclus
breastfeed
abrupt
wean
month
age
histor
control
feed
schedul
without
postnat
matern
haart
treatment
group
cumul
hiv
transmiss
week
month
month
age
cumul
hiv
infect
death
rate
month
month
age
cumul
risk
hiv
transmiss
month
hiv
transmiss
treatment
group
half
transmiss
rate
histor
control
group
anoth
studi
subsaharan
africa
month
matern
haart
exclus
breastfeed
month
demonstr
hivfre
surviv
month
age
matern
infant
mortal
rate
treat
motherinf
pair
significantli
lower
countri
matern
infant
mortal
rate
antiretrovir
therapi
prophylaxi
infant
anoth
investig
intervent
decreas
hiv
transmiss
via
breastfeed
studi
cote
divoir
compar
differ
group
time
infant
receiv
zidovudin
zdv
alon
zdv
prophylaxi
singl
dose
nevirapin
nvp
day
zidovudin
zdv
nvp
zdv
prophylaxi
singl
dose
nevirapin
plu
zidovudin
lamivudin
day
prophylaxi
formula
feed
ff
compar
exclus
shorten
breastfeed
esb
upto
month
age
prolong
breastfeed
pb
cumul
transmiss
rate
month
infant
zdv
pb
group
infant
nvpzdv
esb
group
infant
nvpzdv
ff
group
infant
esb
group
infant
ff
group
kumwenda
et
al
work
malawi
demonstr
decreas
hiv
transmiss
breastfeed
two
differ
infant
prophylaxi
regimen
month
age
observ
occurr
hiv
transmiss
infant
receiv
singl
dose
nevirapin
plu
week
zidovudin
compar
group
receiv
singl
dose
nevirapin
plu
week
zidovudin
plu
week
daili
nevirapin
group
receiv
singl
dose
nevirapin
plu
week
zidovudin
plu
week
nevirapin
zidovudin
mitra
studi
tanzania
median
time
breastfeed
week
hiv
transmiss
rate
month
infant
receiv
zidovudin
plu
week
plu
alon
breastfeed
month
age
less
transmiss
rate
infant
receiv
week
zidovudin
plu
summari
three
trial
ethiopa
india
uganda
compar
singl
dose
nevirapin
birth
infant
week
daili
nevirapin
predominantli
breastf
infant
whose
mother
counsel
regard
feed
per
unicef
guidelin
month
infant
singledos
group
extendeddos
group
hiv
infect
statist
signific
author
suggest
longer
cours
infant
antiretrovir
prophylaxi
might
effect
potenti
effect
breastfeed
hivposit
mother
need
adequ
assess
relat
mother
health
statu
uganda
zimbabw
mbizvo
et
al
report
differ
number
hospit
admiss
mortal
hivposit
hivneg
women
pregnanc
year
deliveri
hivposit
women
higher
hospit
admiss
approxim
two
time
increas
risk
death
rate
rel
risk
greater
hivneg
women
chilongozi
et
al
report
hivposit
mother
four
subsaharan
site
follow
month
seriou
advers
event
occur
women
death
occur
hivposit
women
death
occur
hivneg
women
sever
studi
examin
breastfeed
rel
mother
health
report
conflict
result
first
studi
kenya
demonstr
significantli
higher
mortal
rate
breastfeed
mother
compar
formulafeed
group
year
deliveri
hypothes
explan
offer
author
differ
increas
metabol
demand
greater
weight
loss
nutrit
deplet
second
studi
south
africa
show
overal
lower
mortal
rate
two
group
signific
differ
mortal
rate
month
observ
kuhn
et
al
report
differ
mortal
month
deliveri
women
randomli
assign
short
breastfeed
group
women
median
breastfeed
durat
month
still
breastfeed
month
long
breastfeed
group
women
breastfeed
month
breastfeed
month
median
month
hivrel
mortal
rate
high
associ
prolong
lactat
walson
et
al
follow
hivposit
women
year
kenya
mortal
risk
year
year
followup
although
less
women
report
hospit
year
experienc
variou
common
infect
pneumonia
diarrhea
tb
malaria
std
urinari
tract
infect
mastiti
breastfeed
signific
cofactor
diarrhea
mastiti
pneumonia
tb
hospit
summari
breastfeed
infant
hivposit
mother
lead
increas
risk
hiv
infect
infant
much
remain
understood
mechan
hiv
transmiss
via
breast
milk
action
efficaci
differ
intervent
prevent
transmiss
complet
avoid
breastfeed
crucial
compon
prevent
perinat
hiv
infect
unit
state
mani
countri
resourcepoor
set
breastfeed
norm
provid
vital
nutrit
infect
protect
benefit
unicef
joint
unit
nation
programm
hiv
aid
unaid
recommend
educ
counsel
support
hivinfect
mother
make
inform
choic
concern
infant
feed
mother
choos
breastfe
receiv
addit
educ
support
medic
care
minim
risk
hiv
transmiss
optim
health
statu
breastfeed
mother
choos
use
replac
feed
receiv
parallel
educ
support
medic
care
infant
minim
effect
lack
breastfeed
good
evid
show
antiretrovir
prophylact
regimen
mother
infant
continu
breastfeed
decreas
postnat
hiv
transmiss
earli
wean
associ
increas
morbid
mortal
care
control
research
indic
adequ
assess
risk
benefit
infant
mother
prolong
breastfeed
antiretrovir
prophylaxi
either
mother
infant
along
hiv
test
rate
must
improv
time
increas
avail
access
antenat
care
hiv
prevent
servic
hiv
medic
care
everyon
must
increas
avail
free
access
antiretrovir
medic
must
also
improv
decis
infant
feed
hivposit
mother
remain
difficult
one
slowli
chang
increas
option
goal
remain
hiv
transmiss
prevent
optim
matern
health
surviv
longterm
infant
health
surviv
human
immunodefici
viru
type
rna
viru
nononcogen
cytopath
lentiviru
genu
retrovirus
genet
closer
simian
immunodefici
viru
clinic
diseas
associ
similar
symptom
infect
progress
slower
rate
sever
immunosuppress
endem
western
africa
part
caribbean
found
infrequ
europ
north
south
america
transmit
via
sexual
contact
blood
blood
product
mother
child
routin
test
recommend
blood
bank
antibodi
test
use
sensit
detect
specif
test
appropri
whenev
clinic
epidemiolog
indic
vertic
transmiss
occur
infrequ
ekpini
et
al
follow
larg
cohort
west
african
mother
infant
posit
women
posit
women
women
seroposit
hiv
seroneg
women
case
perinat
transmiss
occur
case
late
postnat
transmiss
observ
probabl
transmiss
via
breast
milk
less
common
insuffici
data
support
risk
transmiss
zero
mother
test
posit
test
guidelin
breastfeed
follow
addit
inform
avail
rabi
viru
produc
sever
infect
progress
cn
symptom
anxieti
seizur
alter
mental
statu
ultim
proce
death
report
surviv
exist
rabi
occur
worldwid
except
australia
antarctica
sever
island
group
case
rabi
report
number
probabl
mark
underestim
actual
case
case
human
rabi
report
unit
state
postexposur
prophylaxi
given
thousand
patient
year
rabi
viru
endem
variou
anim
popul
includ
raccoon
skunk
fox
bat
aggress
immun
program
rabi
domest
dog
cat
unit
state
uncommon
viru
found
saliva
tear
nervou
tissu
infect
anim
transmiss
occur
bite
lick
simpli
contact
oral
secret
mucou
membran
nonintact
skin
mani
case
rabi
human
lack
histori
obviou
contact
rabid
anim
may
result
long
incub
period
gener
week
year
report
incub
period
sever
year
lack
symptom
earli
infecti
anim
airborn
transmiss
bat
enclos
environ
cave
laboratori
hous
persontoperson
transmiss
via
bite
document
although
occur
corneal
transplant
rabi
viremia
observ
spread
viru
evid
exist
indic
transmiss
breast
milk
case
matern
infect
rabi
mani
scenario
occur
onset
progress
sever
cn
symptom
progress
sever
matern
ill
preclud
breastfeed
separ
infant
mother
appropri
regardless
mother
statu
method
infant
feed
especi
avoid
contact
saliva
tear
breastfeed
continu
mother
symptom
rabi
infant
receiv
postexposur
immun
close
observ
infant
may
receiv
express
breast
milk
express
must
occur
without
possibl
contamin
saliva
tear
mother
depend
scenario
natur
mother
ill
possibl
exposur
infant
sourc
mother
exposur
child
mother
postexposur
immun
infant
may
appropri
common
scenario
mother
appar
exposur
rabi
without
exposur
infant
necessit
postexposur
immun
mother
rabi
vaccin
major
case
absenc
matern
ill
breastfeed
reason
continu
mother
fivedos
immun
seri
day
rare
situat
appar
exposur
mother
infant
rabi
occur
togeth
postexposur
treatment
mother
infant
institut
breastfeed
continu
respiratori
syncyti
viru
rsv
common
caus
respiratori
ill
children
rel
common
adult
usual
produc
milder
upper
respiratori
tract
infect
adult
evid
indic
rsv
caus
intrauterin
infect
advers
affect
fetu
caus
abort
prematur
rsv
produc
infect
neonat
caus
asymptomat
infect
afebril
upper
respiratori
tract
infect
bronchiol
pneumonia
apnea
mortal
rate
high
neonat
especi
prematur
infant
ill
fullterm
infant
particularli
preexist
respiratori
diseas
hyalin
membran
diseas
bronchopulmonari
dysplasia
cardiac
diseas
associ
pulmonari
hypertens
rsv
believ
transmit
via
droplet
direct
contact
conjunctiva
nasal
mucosa
oropharynx
infect
respiratori
secret
document
rsv
infect
rare
made
adult
spread
mother
household
contact
probabl
occur
diagnosi
made
therefor
risk
rsv
transmiss
breast
milk
probabl
insignific
compar
transmiss
via
direct
droplet
contact
famili
nurseri
howev
appropri
make
time
diagnosi
rsv
infect
neonat
isol
infant
other
prevent
spread
nurseri
ribavirin
recommend
routin
use
infrequ
use
patient
potenti
lifethreaten
rsv
infect
rsv
infect
suspect
infant
rhinorrhea
nasal
congest
unexplain
apnea
especi
octob
march
temper
climat
prophylaxi
rsv
rsvspecif
immunoglobulin
iv
rsvigiv
season
infant
highest
risk
sever
diseas
appropri
debat
surround
topic
effect
passiv
acquir
antibodi
infant
mother
birth
rsv
occurr
sever
ill
neonat
infant
appear
higher
level
neutral
antibodi
rsv
neonat
decreas
risk
sever
rsv
diseas
controversi
remain
concern
measur
benefit
breastfeed
prevent
seriou
rsv
diseas
studi
shown
benefit
other
effect
control
possibl
confound
factor
eg
smoke
crowd
live
condit
studi
difficult
point
reason
exist
stop
breastfeed
matern
rsv
infect
potenti
exist
benefit
nonspecif
factor
breast
milk
rsv
infant
rsv
infect
breastfe
unless
respiratori
statu
preclud
rotaviru
infect
usual
result
diarrhea
accompani
emesi
lowgrad
fever
sever
infect
clinic
cours
includ
dehydr
electrolyt
abnorm
acidosi
contribut
malnutrit
develop
countri
gener
everi
child
least
one
episod
rotaviru
infect
year
age
develop
countri
rotaviru
often
associ
diarrhea
requir
hospit
children
younger
year
age
rare
associ
death
worldwid
rotaviru
lead
caus
diarrhearel
death
children
younger
year
old
estim
suggest
children
younger
year
old
rotaviru
infect
lead
million
occurr
diarrhea
million
hospit
admiss
death
year
fecalor
transmiss
common
rout
fomit
respiratori
spread
may
also
occur
spread
infect
occur
often
home
young
children
daycar
center
institut
hospit
infant
mother
rotaviru
infect
contact
precaut
indic
durat
ill
evid
indic
prenat
infect
rotaviru
perinat
postnat
infect
contact
mother
other
occur
case
transmiss
rotaviru
via
breast
milk
document
breast
milk
contain
antibodi
rotaviru
year
human
milk
mucin
demonstr
inhibit
rotaviru
replic
prevent
experiment
gastroenter
mechan
rotaviru
immun
well
understood
thought
multifactori
cellmedi
immun
limit
sever
cours
infect
humor
immun
protect
subsequ
infect
innat
adapt
respons
level
mucosa
probabl
import
exclus
breastfeed
may
decreas
likelihood
sever
rotavirusrel
diarrhea
much
although
breastfeed
prevent
infect
rotaviru
seem
decreas
sever
rotavirusinduc
ill
children
younger
year
old
least
one
studi
suggest
may
repres
simpli
postpon
sever
rotaviru
infect
older
age
one
studi
suggest
protect
rotaviru
rapidli
declin
upon
discontinu
breastfeed
delay
rotaviru
infect
child
older
may
benefici
older
child
may
abl
toler
infect
ill
lower
likelihood
becom
dehydr
malnourish
continu
breastfeed
episod
rotaviru
ill
without
vomit
appropri
often
help
infant
reason
suspend
breastfeed
mother
infect
rotaviru
appar
two
rotaviru
vaccin
rotateq
rotarix
licens
use
countri
less
countri
routin
immun
program
addit
type
rotaviru
vaccin
undergo
studi
variou
countri
specif
examin
efficaci
vaccin
low
medium
incom
countri
explan
slow
implement
effect
vaccin
global
includ
differ
protect
specif
vaccin
high
incom
countri
compar
low
medium
incom
countri
unfortun
associ
intussuscept
unit
state
delay
recognit
signific
rotavirusrel
morbid
mortal
cost
new
vaccin
question
variabl
efficaci
specif
rotaviru
vaccin
develop
develop
countri
remain
import
one
sever
trial
examin
issu
attempt
address
factor
matern
transplacent
transfer
antibodi
breastfeed
practic
especi
immedi
immun
live
oral
rotaviru
vaccin
stomach
acid
micronutri
malnutrit
interf
gut
flora
differ
epidemiolog
rotaviru
differ
locat
evid
indic
matern
immun
rotaviru
vaccin
increas
transplacent
acquisit
antibodi
secretori
iga
breast
milk
addit
oral
rotaviru
vaccin
abl
stimul
good
serolog
respons
formulaf
breastf
infant
although
antigen
titer
may
need
modifi
creat
optim
respons
infant
actual
protect
effect
vaccin
differ
situat
strategi
requir
measur
ongo
prospect
studi
congenit
rubella
infect
well
describ
contribut
variabl
infect
sever
diseas
elucid
primari
intervent
prevent
congenit
rubella
establish
exist
matern
immun
rubella
concept
includ
immun
rubella
vaccin
reimmun
indic
perinat
infect
clinic
signific
postnat
infect
occur
infrequ
children
younger
year
age
passiv
acquir
matern
antibodi
predomin
age
infect
year
old
half
infect
asymptomat
postnat
rubella
selflimit
mild
viral
infect
associ
evanesc
rash
shotti
adenopathi
lowgrad
transient
fever
often
occur
late
winter
spring
infant
congenit
infect
shed
viru
prolong
period
variou
site
may
serv
sourc
infect
throughout
year
contact
isol
appropri
suspect
prove
congenit
infect
least
year
includ
exclus
day
care
avoid
pregnant
women
wherea
postnat
rubella
infect
requir
droplet
precaut
day
onset
rash
rubella
viru
isol
breast
milk
natur
infect
congenit
postnat
immun
live
attenu
vaccin
viru
iga
antibodi
immunoreact
cell
rubella
identifi
breast
milk
breastf
infant
acquir
vaccin
viru
infect
via
milk
asymptomat
postpartum
infect
viru
natur
vaccin
associ
clinic
signific
ill
reason
exist
prevent
breastfeed
congenit
infect
postpartum
infect
viru
matern
immun
rubella
vaccin
sever
acut
respiratori
syndrom
sar
term
could
appli
acut
seriou
respiratori
ill
caus
associ
varieti
infect
agent
sinc
howev
link
sarsassoci
coronaviru
sarscov
global
outbreak
probabl
case
sar
death
occur
actual
number
affect
individu
associ
mortal
rate
approxim
overal
closer
person
older
year
age
know
new
unusu
ill
tremend
public
surround
made
sar
sensat
know
caus
ill
known
sarscov
sarscov
shown
close
relat
previous
character
coronaviru
group
despit
intens
intern
collabor
studi
ill
viru
mani
thing
known
degre
infecti
actual
period
transmiss
mode
transmiss
mani
peopl
asymptomat
infect
compar
symptom
sever
ill
make
rapid
diagnosi
confirm
case
origin
least
case
probabl
sar
children
describ
literatur
gener
ill
children
mild
nonspecif
respiratori
ill
adolesc
adult
like
progress
sever
respiratori
distress
report
children
less
like
transmit
sar
adult
overal
clinic
cours
radiolog
evolut
histolog
find
ill
consist
host
immun
respons
play
signific
role
diseas
product
five
infant
born
mother
confirm
sar
infant
born
prematur
week
presum
due
matern
ill
although
two
five
infant
seriou
abdomin
ill
coronavirus
associ
report
outbreak
necrot
enterocol
presenc
sarscov
could
demonstr
infant
evid
vertic
transmiss
sar
avail
mode
feed
report
case
young
children
sar
infant
born
mother
sar
mention
respiratori
virus
predominantli
transmit
droplet
transmiss
via
breast
milk
insignific
mode
transmiss
occur
benefit
breastfeed
mother
sar
continu
breastfeed
abl
express
breast
milk
given
infant
mother
abl
breastfe
era
worri
biolog
terror
smallpox
import
concern
concern
infant
breastf
formulaf
direct
contact
mother
household
member
smallpox
smallpox
highli
contagi
household
set
due
persontoperson
spread
via
droplet
nuclei
aerosol
oropharynx
direct
contact
rash
addit
potenti
exposur
infant
includ
releas
smallpox
aerosol
environ
terrorist
contact
smallpoxcontamin
space
cloth
household
member
expos
aerosol
infect
via
contact
mother
household
member
smallpox
vaccin
site
risk
breastf
formulaf
infant
evid
transmiss
smallpox
viru
via
breast
milk
exist
contact
defin
person
household
facetofac
contact
patient
smallpox
onset
fever
patient
transmit
infect
progress
fever
stage
develop
rash
expos
contact
need
isol
other
postcontact
observ
period
usual
day
person
develop
fever
temperatur
monitor
daili
expos
contact
person
contact
breastfeed
mother
infant
continu
onset
fever
immedi
isol
home
begin
provid
express
breast
milk
infant
mother
smallpox
avoid
extens
natur
smallpox
rash
possibl
contamin
rash
milk
express
process
literatur
document
transmiss
smallpox
viru
via
express
breast
milk
issu
breastfeed
infant
question
matern
vaccin
smallpox
preexposur
event
vaccin
program
children
older
year
age
safe
reason
vaccin
smallpox
face
probabl
smallpox
exposur
smallpox
vaccin
infant
younger
year
age
contraind
breastfeed
list
contraind
vaccin
preevent
vaccin
program
unknown
whether
vaccin
viru
antibodi
present
breast
milk
risk
infect
due
contact
aerosol
viru
mother
smallpox
vaccin
site
breastf
formulaf
infant
advisori
committe
immun
practic
also
recommend
preevent
smallpox
vaccin
children
younger
year
old
report
document
tertiari
contact
vaccinia
breastfeed
infant
unit
state
militari
person
receiv
primari
smallpox
vaccin
develop
local
reaction
inocul
site
despit
reportedli
observ
appropri
precaut
individu
wife
develop
vesicl
areola
secondari
contact
vaccinia
subsequ
breastfeed
infant
develop
lesion
philtrum
cheek
tongu
mother
infant
remain
well
infect
resolv
without
therapi
cultur
pcr
test
confirm
vaccinia
mother
infant
lesion
breast
milk
test
review
sepkowitz
report
case
secondari
vaccinia
household
cdc
report
suspect
case
secondarytertiari
vaccinia
case
confirm
cultur
pcr
case
relat
vaccin
militari
personnel
incid
case
per
vac
cine
case
per
primari
vaccine
separ
report
civilian
preevent
smallpox
vaccin
program
individu
vaccin
januari
june
case
contact
vaccinia
report
risk
contact
vaccinia
low
risk
close
intim
contact
abovement
case
risk
infant
contact
mother
breast
inadvert
site
contact
vaccinia
breastf
formulaf
infant
equal
risk
close
contact
household
smallpox
vaccine
case
secondari
vaccinia
separ
individu
appropri
situat
breast
nurs
mother
involv
express
breast
milk
given
infant
tt
viru
ttv
recent
identifi
viru
found
patient
tt
posttransfus
hepat
associ
hepatitisrel
virus
g
ttv
describ
unenvelop
circular
singlestrand
dna
viru
viru
preval
healthi
individu
includ
healthi
blood
donor
identifi
patient
hepat
ttv
dna
detect
infant
ttvposit
ttvneg
mother
ohto
et
al
report
ttv
dna
detect
cord
blood
infant
detect
sampl
taken
month
age
note
increas
preval
month
year
ascrib
acquisit
via
nonparenter
rout
comparison
ttv
dna
ttvposit
mother
ttvposit
infant
show
high
level
nucleotid
sequenc
similar
differ
greater
et
al
report
ttv
dna
breast
milk
examin
retrospect
notabl
ttv
dna
detect
serum
sampl
infant
week
age
born
women
virem
ttv
dna
twentyfour
women
neg
ttv
dna
gave
birth
children
initi
neg
ttv
dna
remain
neg
throughout
observ
period
mean
month
rang
month
ttv
dna
detect
breast
milk
sampl
ttv
virem
women
none
breast
milk
sampl
ttvneg
women
clinic
laboratori
evid
hepat
found
children
observ
ttv
dna
posit
period
studi
author
report
ttv
breast
milk
detect
pcr
describ
absenc
ttv
dna
infant
day
month
age
infant
posit
ttv
dna
month
age
suggest
late
acquisit
infect
via
breastfeed
tt
viru
transmit
utero
found
breast
milk
evid
clinic
hepat
infant
relat
ttv
infect
evid
late
chronic
hepat
exist
given
current
avail
inform
reason
proscrib
breastfeed
ttvposit
mother
compel
certainli
need
understood
concern
chronic
natur
infect
possibl
pathogenesi
liver
diseas
document
evid
indic
women
breast
cancer
rna
tumor
viru
milk
correl
rnadirect
dna
polymeras
activ
found
women
famili
histori
breast
cancer
rnadirect
dna
polymeras
activ
reserv
transcriptas
normal
featur
lactat
breast
epidemiolog
data
conflict
suggest
tumor
agent
transmit
breast
milk
incid
breast
cancer
low
among
group
nurs
infant
includ
lower
econom
group
foreignborn
group
spars
popul
area
frequenc
breast
cancer
mother
sister
woman
breast
cancer
two
three
time
expect
chanc
could
genet
environment
cancer
actual
equal
common
side
famili
affect
woman
breast
milk
caus
transmit
mother
daughter
motherdaught
incid
cancer
studi
relationship
found
breastfeed
sarkar
et
al
report
human
milk
incub
mous
mammari
tumor
viru
caus
degrad
particular
morpholog
decreas
infect
revers
transcriptas
activ
virion
suggest
signific
destruct
effect
human
milk
mous
mammari
tumor
viru
may
account
difficulti
isol
put
human
mammari
tumor
agent
sanner
show
inhibitori
enzym
milk
remov
special
sediment
techniqu
ascrib
discrep
isol
viru
particl
human
milk
factor
inhibit
rnadirect
dna
po
lymeras
fear
cancer
breastf
femal
offspr
woman
breast
cancer
justifi
avoid
breastfeed
breastf
women
breast
cancer
experi
nonbreastf
women
increas
seen
benign
tumor
daughter
breast
cancer
patient
increas
risk
develop
benign
malign
tumor
hered
breastfeed
histori
unilater
breastfeed
limit
right
breast
custom
tanka
women
fish
villag
hong
kong
ing
et
al
investig
question
unsuckl
breast
alter
risk
cancer
studi
breast
cancer
data
breast
cancer
occur
equal
left
right
breast
comparison
patient
nurs
unilater
nullipar
patient
patient
born
children
breastf
indic
highli
significantli
increas
risk
cancer
unsuckl
breast
author
conclud
postmenopaus
women
breastf
unilater
risk
cancer
significantli
higher
unsuckl
breast
thought
breastfeed
may
help
protect
suckl
breast
cancer
other
suggest
tanka
women
ethnic
separ
peopl
leftsid
breast
cancer
may
relat
genet
pool
breastfeed
habit
mention
made
possibl
influenc
impact
role
fishermen
inher
trauma
left
breast
laneclaypon
state
breast
never
lactat
liabl
becom
cancer
nullipar
absenc
breastfeed
consid
import
risk
factor
breast
cancer
macmahon
et
al
report
age
first
fullterm
pregnanc
compel
factor
younger
mother
less
risk
collect
review
etiolog
factor
cancer
breast
human
papaioann
conclud
genet
factor
virus
hormon
psychogen
stress
diet
possibl
factor
probabl
order
import
contribut
extent
develop
cancer
breast
wing
conclud
review
human
milk
health
view
complet
absenc
studi
show
relationship
breastfeed
increas
risk
breast
cancer
presenc
viruslik
particl
breast
milk
contraind
breastfeed
henderson
et
al
gradual
studi
appear
challeng
dogma
brinton
et
al
mctiernan
thoma
layd
et
al
show
clearli
protect
effect
breastfeed
anoth
exampl
studi
conduct
clarifi
whether
lactat
protect
role
breast
cancer
asian
peopl
regardless
confound
effect
age
first
pregnanc
pariti
close
relat
factor
hospitalbas
casecontrol
studi
women
without
breast
cancer
statist
adjust
potenti
confound
likelihood
ratio
test
linear
trend
done
uncondit
logist
regress
total
month
lactat
regardless
pariti
discrimin
regardless
age
first
pregnanc
pariti
lactat
independ
protect
effect
breast
cancer
japanes
women
although
breast
cancer
incid
influenc
genet
stress
hormon
pregnanc
breastfeed
clearli
protect
effect
reduct
risk
breast
cancer
among
premenopaus
women
lactat
reduct
risk
breast
cancer
occur
among
postmenopaus
women
histori
lactat
accord
newcomb
et
al
report
multicent
studi
varicellazost
viru
infect
varicellachickenpox
zostershingl
one
communic
diseas
human
class
measl
smallpox
transmiss
thought
occur
via
respiratori
droplet
viru
vesicl
varicella
pregnanc
rare
event
although
diseas
sever
varicella
pneumonia
fatal
congenit
varicellazost
viru
infect
occur
infrequ
caus
abort
prematur
congenit
malform
syndrom
malform
care
describ
congenit
varicellazost
viru
infect
typic
involv
limb
deform
skin
scar
nerv
damag
includ
eye
brain
perinat
infect
lead
sever
infect
infant
matern
rash
develop
day
less
deliveri
within
day
deliveri
ill
infant
usual
develop
day
age
believ
sever
lack
adequ
transfer
antibodi
mother
period
transplacent
spread
viru
fetu
infant
viremia
mother
varicella
mother
occur
day
deliveri
allow
suffici
format
transplacent
transfer
antibodi
infant
amelior
diseas
even
infant
infect
varicellazost
viru
mother
develop
varicella
rash
day
deliveri
less
like
transfer
viru
infant
transplacent
pose
risk
infant
postnat
exposur
diminish
administr
varicellazost
ig
infant
postnat
transmiss
believ
occur
aerosol
viru
skin
lesion
respiratori
tract
enter
suscept
infant
respiratori
tract
airborn
precaut
therefor
appropri
hospit
set
infant
infect
varicellazost
viru
utero
perinat
period
younger
month
age
like
develop
zoster
reactiv
latent
varicellazost
viru
childhood
young
adult
postnat
varicella
nonmatern
exposur
occur
gener
mild
develop
week
age
mother
pass
antibodi
varicellazost
viru
via
placenta
sever
postnat
varicella
occur
prematur
infant
infant
varicellasuscept
mother
mother
immun
statu
rel
varicellazost
viru
uncertain
measur
antibodi
varicellazost
viru
mother
infant
perform
promptli
less
hour
administr
vzig
ivig
infant
expos
varicella
zoster
postnat
period
indic
ideal
mother
varicella
statu
known
pregnanc
varicella
viru
vaccin
could
given
indic
varicellazost
viru
viru
cultur
milk
varicellazost
viru
dna
identifi
breast
milk
antibodi
varicellazost
viru
also
found
breast
milk
breast
milk
mother
receiv
varicella
vaccin
postpartum
period
test
varicellazost
viru
dna
varicella
dna
detect
breast
milk
sampl
women
seroconvert
vaccin
one
case
suspect
transfer
varicellazost
viru
infant
via
breastfeed
report
viru
may
transmit
respiratori
droplet
exposur
rash
mother
began
antivir
therapi
isol
infant
mother
varicella
interrupt
breastfeed
occur
mother
remain
clinic
infecti
regardless
method
feed
soon
infant
receiv
varicellazost
ig
express
breast
milk
given
infant
skin
lesion
involv
breast
person
varicella
rash
consid
noninfecti
new
vesicl
appear
hour
lesion
crust
usual
day
immunocompet
mother
develop
zoster
continu
breastfe
lesion
involv
breast
cover
antibodi
varicellazost
viru
provid
infant
via
placenta
breast
milk
diminish
sever
diseas
even
prevent
conserv
manag
scenario
would
includ
give
infant
varicellazost
ig
well
see
tabl
estim
asymptomat
case
west
nile
infect
occur
everi
febril
ill
everi
one
case
meningoenceph
associ
west
nile
viru
west
nile
fever
usual
mild
ill
day
durat
symptom
rel
nonspecif
includ
malais
nausea
vomit
headach
myalgia
lymphadenopathi
rash
west
nile
diseas
character
sever
neurolog
symptom
eg
mening
enceph
acut
flaccid
paralysi
occasion
optic
neuriti
cranial
nerv
abnorm
seizur
children
infrequ
sick
west
nile
viru
infect
infant
younger
year
age
rare
report
casefat
rate
unit
state
approxim
report
high
hospit
patient
casefat
rate
person
older
year
age
consid
higher
among
hospit
patient
outbreak
romania
israel
primari
mechan
transmiss
via
mosquito
bite
mosquito
genu
culex
primari
vector
birdmosquitobird
cycl
serv
maintain
amplifi
viru
environ
human
hors
incident
host
pathogenesi
infect
believ
occur
via
replic
viru
skin
lymph
node
lead
primari
viremia
seed
secondari
site
second
viremia
caus
infect
cn
affect
organ
transmiss
report
rare
instanc
pregnanc
via
organ
transplant
percutan
laboratori
worker
studi
west
nile
viru
infect
pregnanc
document
four
miscarriag
two
elect
abort
live
birth
cord
blood
sampl
test
infant
neg
antiwest
nile
viru
igm
three
infant
west
nile
viru
infect
could
acquir
congenit
three
infant
congenit
malform
might
caus
matern
west
nile
viru
infect
base
time
pregnanc
evid
west
nile
viru
etiolog
conclus
west
nile
viru
transmiss
occur
via
blood
blood
product
transfus
incid
estim
high
per
donat
epidem
specif
citi
evid
direct
persontoperson
transmiss
without
mosquito
vector
found
one
case
possibl
west
nile
viru
transmiss
via
breastfeed
document
mother
acquir
viru
via
pack
rbc
transfus
deliveri
second
unit
blood
receiv
associ
blood
product
donat
caus
west
nile
infect
anoth
transfus
recipi
eight
day
later
mother
sever
headach
hospit
fever
csf
pleocytosi
day
deliveri
mother
csf
posit
west
nile
virusspecif
igm
antibodi
infant
breastf
birth
second
day
hospit
mother
sampl
breast
milk
west
nile
virusspecif
igg
igm
posit
day
deliveri
west
nile
virusspecif
igm
posit
day
milk
west
nile
viru
rna
posit
pcr
test
day
day
deliveri
infant
test
posit
west
nile
virusspecif
igm
serum
day
age
remain
well
without
fever
clearcut
exposur
mosquito
infant
report
cord
blood
placenta
avail
test
igm
antibodi
found
low
concentr
breast
milk
common
effici
transfer
iga
secretori
iga
igg
breast
milk
review
west
nile
viru
ill
breastfeed
identifi
six
occurr
breastfeed
matern
west
nile
viru
ill
five
six
infant
ill
detect
antibodi
west
nile
viru
blood
one
infant
develop
rash
otherwis
well
matern
west
nile
viru
ill
test
west
nile
viru
infect
two
infant
identifi
develop
west
nile
viru
ill
breastfeed
preced
west
nile
viru
infect
demonstr
mother
two
breastfeed
infant
develop
west
nile
virusspecif
antibodi
mother
acquir
west
nile
viru
ill
last
week
pregnanc
congenit
infect
could
rule
live
viru
cultur
sampl
breast
milk
mother
infect
west
nile
viru
pregnanc
west
nile
viru
rna
detect
two
sampl
sampl
igm
antibodi
west
nile
viru
data
suggest
west
nile
viru
infect
breastfeed
rare
date
evid
signific
diseas
due
west
nile
viru
infect
young
breastfeed
children
lack
time
reason
exist
proscrib
breastfeed
case
matern
west
nile
viru
infect
mother
well
enough
breastfe
mani
matern
viral
ill
time
diagnosi
made
mother
infant
may
alreadi
expos
matern
viremia
possibl
virolactia
infant
continu
receiv
breast
milk
potenti
specif
nonspecif
antivir
immunolog
benefit
yellow
fever
viru
flaviviru
transmit
human
infect
aed
haemogogu
mosquito
tropic
area
south
america
africa
larg
outbreak
occur
mosquito
popul
area
becom
infect
bite
virem
human
infect
yellow
fever
viru
transmiss
mosquito
human
occur
incub
period
mosquito
day
direct
persontoperson
spread
report
ill
due
yellow
fever
viru
usual
begin
incub
period
day
acut
onset
headach
fever
chill
myalgia
photophobia
back
pain
anorexia
vomit
restless
common
symptom
individu
usual
virem
first
day
ill
fever
symptom
diminish
liver
dysfunct
even
failur
develop
myocardi
dysfunct
cn
infect
uncommon
symptom
includ
seizur
coma
medic
care
includ
intens
support
care
fluid
manag
one
case
congenit
infect
immun
pregnant
woman
attenu
vaccin
strain
report
one
infant
whose
mother
inadvert
receiv
yellow
fever
viru
vaccin
pregnanc
develop
igm
elev
neutral
antibodi
yellow
fever
viru
without
evid
ill
abnorm
recent
studi
brazil
examin
inadvert
yellow
fever
viru
immun
pregnanc
mass
vaccin
campaign
pregnant
women
receiv
yellow
fever
viru
mean
week
gestat
major
know
pregnanc
statu
time
seroconvers
occur
women
least
week
vaccin
mild
postvaccin
ill
headach
fever
myalgia
report
women
frequenc
malform
miscarriag
stillbirth
prematur
deliveri
similar
found
gener
popul
followup
point
infant
still
demonstr
neutral
antibodi
yellow
fever
viru
month
one
child
still
seroposit
transmiss
yellow
fever
vaccin
viru
breastfeed
recent
report
brazil
mother
immun
yellow
fever
epidem
nonendem
area
brazil
day
deliv
healthi
femal
infant
week
gestat
age
mother
receiv
yellow
fever
vaccin
day
later
mother
report
headach
malais
lowgrad
fever
persist
day
mother
continu
breastfeed
seek
medic
care
day
age
infant
becam
irrit
develop
fever
refus
nurs
infant
develop
seizur
subsequ
evalu
infant
demonstr
abnorm
csf
ct
brain
show
bilater
area
diffus
low
densiti
suggest
inflamm
consist
enceph
yellow
feverspecif
igm
antibodi
identifi
infant
serum
csf
reversetranscriptas
polymeras
chain
reaction
rtpcr
test
csf
also
demonstr
yellow
fever
viru
rna
ident
yellow
fever
vaccin
viru
breast
milk
matern
serum
test
yellow
fever
viru
yellow
fever
viru
wild
vaccin
type
identifi
human
breast
milk
although
anoth
flaviviru
west
nile
viru
detect
milk
lactat
women
west
nile
viru
infect
see
section
west
nile
viru
yellow
fever
vaccineassoci
neurolog
diseas
occur
differ
rate
differ
agegroup
includ
case
per
infant
younger
month
age
yellow
fever
vaccin
contraind
infant
younger
month
age
sinc
advisori
committe
immun
practic
recommend
base
theoret
risk
yellow
fever
vaccin
avoid
nurs
mother
except
exposur
highrisk
yellow
fever
endem
area
like
occur
case
transmiss
yellow
fever
viru
infect
mother
infant
via
breastfeed
breast
milk
report
publish
inform
sever
yellow
fever
viru
infect
infant
younger
year
age
potenti
protect
passiv
acquir
antibodi
protect
breast
milk
limit
inform
differenti
risk
breastf
versu
formulaf
infant
avail
given
well
document
method
transmiss
yellow
fever
viru
via
mosquito
lack
evid
transmiss
via
breast
milk
make
sens
protect
infant
mosquito
bite
proscrib
breastfeed
even
mother
infect
yellow
fever
viru
continu
breastfeed
use
express
breast
milk
depend
mother
health
statu
abil
maintain
milk
suppli
acut
ill
anoth
sourc
feed
readili
avail
temporarili
discard
express
breast
milk
least
day
acut
ill
mother
reason
precaut
lyme
diseas
human
ill
caus
spirochet
especi
syphili
character
protean
cours
distinct
phase
stage
diseas
lyme
borreliosi
describ
europ
earli
twentieth
centuri
sinc
tremend
recognit
descript
investig
lyme
diseas
occur
unit
state
europ
public
concern
surround
ill
dramat
lyme
diseas
multisystem
diseas
character
involv
skin
heart
joint
nervou
system
peripher
central
stage
diseas
identifi
earli
local
erythema
migran
often
accompani
arthralgia
neck
stiff
fever
malais
headach
earli
dissemin
multipl
erythema
migran
lesion
cranial
nerv
palsi
mening
conjunct
arthralgia
myalgia
headach
fatigu
rare
myocard
late
diseas
recurr
arthriti
encephalopathi
neuropathi
vari
manifest
diseas
may
relat
degre
spirochetemia
extent
dissemin
specif
tissu
host
immunolog
respons
diagnosi
lyme
diseas
often
difficult
part
broad
spectrum
present
inappar
exposur
tick
lack
adequ
standard
serolog
test
cultur
spirochet
borrelia
burgdorferi
readili
avail
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
immunoblot
assay
usual
test
pcr
detect
spirochet
dna
requir
addit
test
clinic
situat
clarifi
standard
util
gardner
review
infect
pregnanc
summar
total
advers
outcom
case
report
literatur
advers
outcom
includ
miscarriag
stillbirth
case
perinat
death
congenit
anomali
earlyand
lateonset
progress
infect
infant
silver
review
publish
report
conclud
lyme
diseas
pregnanc
uncommon
even
endem
area
although
spirochet
transmit
transplacent
signific
immun
respons
fetu
often
lack
associ
lyme
infect
congenit
abnorm
weak
littl
publish
inform
exist
whether
b
burgdorferi
transmit
via
breast
milk
one
report
show
detect
b
burgdorferi
dna
pcr
breast
milk
two
lactat
women
untreat
erythema
migran
evid
lyme
diseas
transmiss
spirochet
one
infant
follow
year
attempt
cultur
spirochet
made
possibl
determin
detect
dna
viabl
spirochet
noninfecti
fragment
studi
women
untreat
erythema
migran
detect
b
burgdorferi
dna
urin
still
detect
dna
urin
day
start
treatment
none
month
initi
therapi
ziska
et
al
report
manag
nine
case
lyme
diseas
women
associ
pregnanc
seven
nine
women
symptomat
concept
six
receiv
antibiot
throughout
pregnanc
followup
infant
show
transmiss
lyme
diseas
even
seven
infant
breastf
lack
adequ
inform
transmiss
b
burgdorferi
via
breast
milk
taken
proof
occur
one
extrapol
data
syphili
treponema
pallidum
spirochet
would
prudent
discuss
lack
inform
transmiss
b
burgdorferi
via
breast
milk
mother
parent
consid
withhold
breast
milk
least
therapi
lyme
diseas
begun
complet
infect
occur
pregnanc
treatment
alreadi
complet
infant
breastfe
infect
occur
postpartum
diagnosi
made
postpartum
infant
exposur
may
alreadi
occur
discuss
mother
parent
withhold
versu
continu
breastfeed
appropri
prenat
postnat
exposur
infant
close
observ
empir
therapi
consid
infant
develop
rash
symptom
suggest
lyme
borreliosi
treatment
mother
infant
ceftriaxon
penicillin
amoxicillin
accept
breastfeed
rel
infant
exposur
medic
doxycyclin
administ
day
continu
breastfeed
possibl
dental
stain
neonat
continu
surveil
viabl
organ
breast
milk
evid
transmiss
breastfeed
recommend
larg
bodi
inform
avail
variou
lyme
vaccin
use
dog
vaccin
partial
protect
must
repeat
yearli
preliminari
inform
suggest
vaccin
use
human
safe
produc
good
serolog
respons
protect
efficaci
demonstr
inform
exist
use
pregnanc
breastfeed
syphili
classic
exampl
spirochet
infect
caus
multisystem
diseas
variou
stage
acquir
syphili
congenit
syphili
welldescrib
entiti
acquir
syphili
almost
alway
transmit
direct
sexual
contact
open
lesion
skin
mucou
membran
individu
infect
spirochet
treponema
pallidum
congenit
syphili
occur
infect
across
placenta
placent
time
pregnanc
contact
spirochet
passag
birth
canal
stage
diseas
primari
secondari
tertiari
mother
lead
infect
fetu
transmiss
associ
secondari
syphili
approach
infect
primari
syphili
pregnanc
without
treatment
lead
spontan
abort
stillbirth
perinat
death
case
similar
acquir
syphili
congenit
syphili
manifest
moist
lesion
secret
rhiniti
snuffl
condylomata
lata
bullou
lesion
lesion
secret
contain
numer
spirochet
therefor
highli
infecti
postnat
infect
infant
occur
contact
open
moist
lesion
skin
mucou
membran
mother
infect
individu
mother
infant
potenti
infecti
lesion
isol
infant
mother
recommend
lesion
breast
nippl
breastfeed
use
express
milk
contraind
treatment
complet
lesion
clear
spirochet
rare
identifi
open
lesion
hour
appropri
treatment
penicillin
remain
best
therapi
evalu
infant
suspect
syphili
base
mother
clinic
serolog
statu
histori
adequ
therapi
mother
infant
clinic
statu
histolog
examin
placenta
umbil
cord
serolog
test
infant
blood
csf
complet
analysi
csf
long
bone
chest
radiograph
liver
function
test
complet
blood
cell
count
appropri
given
specif
clinic
situat
treatment
infant
follow
recommend
protocol
suspect
probabl
proven
syphilit
infect
evid
indic
transmiss
syphili
via
breast
milk
absenc
breast
nippl
lesion
mother
suspici
breast
lesion
breastfeed
accept
long
appropri
therapi
suspect
proven
syphili
begun
mother
infant
giardiasi
local
infect
limit
intestin
tract
caus
diarrhea
malabsorpt
immunocompet
individu
show
evid
invas
infect
evid
exist
document
fetal
infect
matern
infect
pregnanc
giardiasi
rare
children
younger
month
age
although
neonat
infect
fecal
contamin
birth
describ
human
milk
vivo
protect
effect
giardia
lamblia
infect
document
work
central
africa
end
breastfeed
herald
onset
giardia
infect
reaffirm
undevelop
countri
around
world
protect
effect
breast
milk
identifi
milk
noninfect
donor
antiparasit
effect
result
specif
antibodi
rather
lipas
enzymat
activ
lipas
act
presenc
bile
salt
destroy
trophozoit
emerg
cyst
gi
tract
hernel
et
al
demonstr
free
fatti
acid
mark
giardiacid
effect
support
conclus
lipas
activ
releas
fatti
acid
respons
kill
g
lamblia
g
lamblia
also
report
appear
mother
milk
parasit
transmit
newborn
via
rout
exact
relationship
breastfeed
transmiss
g
lamblia
effect
infant
continu
studi
even
though
symptomat
infect
breastf
infant
rare
one
report
middl
east
suggest
even
partial
breastfeed
protect
infect
intestin
parasit
includ
cryptosporidium
giardia
lamblia
breastfeed
mother
giardiasi
problemat
mainli
medic
use
therapi
metronidazol
safeti
infant
establish
littl
inform
avail
quinacrin
hydrochlorid
furazolidon
breast
milk
paromomycin
nonabsorb
aminoglycosid
reason
altern
recommend
treatment
pregnant
women
breastfeed
mother
symptomat
giardiasi
accept
consider
given
presenc
therapeut
agent
breast
milk
hookworm
infect
often
caus
ancylostoma
duodenal
necat
americanu
common
children
younger
age
year
least
one
report
infantil
hookworm
diseas
china
public
chines
literatur
report
hundr
case
infantil
hookworm
diseas
includ
common
symptom
bloodi
stool
melena
anorexia
listless
edema
anemia
eosinophilia
even
leukemoid
reaction
occur
part
clinic
pictur
young
children
also
note
least
case
hookworm
diseas
newborn
infant
younger
month
age
discuss
infantil
hookworm
infect
note
four
rout
infect
direct
contact
contamin
soil
sandstuf
diaper
contamin
washedwet
diaper
vertic
equal
transmammari
transmiss
transplacent
transmiss
postul
infect
infant
day
age
would
like
due
transplacent
transmiss
infect
environment
contact
would
like
due
transmammari
transmiss
ampl
evid
avail
veterinari
medicin
transmammari
spread
helminth
least
two
report
suggest
possibl
transmammari
transmiss
hookworm
human
setasuban
et
al
describ
preval
necat
americanu
nurs
mother
identifi
n
americanu
breast
milk
one
case
nwosu
document
posit
stool
sampl
hookworm
neonat
week
age
southern
nigeria
major
neonat
infect
due
ancylostoma
duodenal
although
necat
americanu
preval
area
nigeria
examin
colostr
milk
demonstr
hookworm
larva
addit
epidemiolog
work
necessari
determin
potenti
signific
transmammari
spread
helminth
human
care
examin
breast
milk
sourc
hookworm
infect
requir
reason
recommend
possibl
malaria
recogn
major
health
problem
mani
countri
effect
malaria
infect
pregnant
lactat
women
thu
develop
fetu
neonat
grow
infant
signific
four
speci
malaria
plasmodium
vivax
p
oval
p
malaria
p
falciparum
vari
specif
aspect
diseas
produc
p
vivax
exist
throughout
world
p
falciparum
predomin
tropic
problemat
chloroquineresist
form
malaria
unit
state
often
seen
individu
travel
area
malaria
endem
parasit
exist
blood
week
infect
p
vivax
p
malaria
lead
relaps
year
later
transmiss
occur
bite
anophelin
mosquito
occur
via
transfus
blood
product
transplacent
congenit
malaria
rare
seem
occur
often
p
vivax
p
falciparum
usual
present
first
day
life
rang
day
month
may
resembl
neonat
sepsi
fever
anemia
splenomegali
occur
neonat
hyperbilirubinemia
hepatomegali
less
half
malaria
infant
younger
month
age
gener
manifest
less
sever
diseas
death
older
children
possibl
explan
includ
effect
less
exposur
mosquito
passiv
antibodi
acquir
mother
high
level
fetal
hemoglobin
infant
age
variat
infect
rate
children
younger
month
age
wet
dri
season
support
idea
postnat
infect
common
congenit
infect
evid
indic
malaria
transmit
breast
milk
greatest
risk
infant
exposur
anophelin
mosquito
infect
malaria
main
issu
rel
malaria
breastfeed
protect
mother
infant
effect
mosquito
drug
treat
malaria
mother
appropri
lactat
protect
mosquito
bite
includ
screenedin
live
area
mosquito
net
sleep
protect
cloth
without
repel
cloth
commun
effort
erad
mosquito
chloroquin
quinin
tetracyclin
accept
breastfeed
sulfonamid
avoid
first
month
infant
life
pyrimethaminesulfadoxin
fansidar
use
later
mefloquin
approv
infant
pregnant
women
howev
milkplasma
ratio
mefloquin
less
larg
volum
distribut
drug
high
protein
bind
drug
limit
presenc
breast
milk
rel
import
breastfeed
area
malaria
preval
shift
riskbenefit
ratio
favor
treatment
mefloquin
singl
dose
recommend
treatment
onceweekli
dose
prevent
allow
continu
breastfeed
discard
milk
short
period
dose
hour
matern
plasma
level
primaquin
rang
ngml
inform
avail
level
human
milk
primaquin
use
children
daili
dose
mother
would
allow
discard
milk
peak
level
drug
therefor
breastfeed
matern
malaria
even
treatment
appropri
specif
medic
strongyloid
stercorali
nematod
roundworm
infect
asymptomat
clinic
signific
infect
human
includ
larval
skin
invas
tissu
migrat
intestin
invas
abdomin
pain
gi
symptom
loefflerlik
syndrom
due
migrat
lung
immunecompromis
individu
develop
dissemin
larva
system
caus
variou
clinic
symptom
human
princip
host
mammal
serv
reservoir
infect
via
skin
filariform
larva
common
form
transmiss
ingest
uncommon
occurr
transmammari
transmiss
strongyloid
speci
describ
dog
ewe
rat
one
report
transmammari
passag
strongyloid
larva
human
avail
infant
younger
day
age
demonstr
presenc
strongyloid
fuelleborni
stool
examin
clinic
signific
elucid
strongyloid
larva
identifi
one
sampl
milk
nurs
mother
absenc
understand
clinic
signific
strongyloid
stool
young
infant
given
lack
exclus
common
mechan
transmiss
skin
singl
report
appar
infrequ
evid
larva
human
milk
difficult
make
recommend
concern
breastfeed
strongyloid
toxoplasmosi
one
common
infect
human
throughout
world
infect
organ
toxoplasma
gondii
ubiquit
natur
preval
posit
serolog
test
titer
increas
age
indic
past
exposur
infect
cat
definit
host
although
infect
occur
speci
warmblood
anim
postnat
infect
toxoplasmosi
usual
asymptomat
symptomat
infect
typic
manifest
nonspecif
symptom
includ
fever
malais
myalgia
sore
throat
lymphadenopathi
rash
hepatosplenomegali
occasion
mononucleosislik
ill
ill
usual
resolv
without
treatment
signific
complic
congenit
infect
infect
immunodefici
individu
persist
sever
caus
signific
morbid
even
death
although
infant
congenit
infect
asymptomat
birth
visual
abnorm
learn
disabl
mental
retard
occur
month
year
later
syndrom
congenit
toxoplasmosi
clearli
defin
sever
manifest
involv
cn
includ
hydrocephalu
cerebr
calcif
microcephali
chorioretin
seizur
simpli
isol
ocular
involv
risk
fetal
infect
relat
time
primari
matern
infect
although
transmiss
occur
preexist
matern
toxoplasmosi
last
month
pregnanc
protozoan
readili
transmit
fetu
infect
like
subclin
earli
pregnanc
transmiss
fetu
occur
less
frequent
result
sever
diseas
treatment
document
congenit
infect
current
recommend
although
durat
optim
regimen
determin
revers
preexist
sequela
gener
occur
prevent
infect
suscept
pregnant
women
possibl
avoid
exposur
cat
fece
organ
soil
pregnant
lactat
women
chang
cat
litter
box
must
done
daili
wear
glove
oocyst
infect
first
hour
passag
mother
avoid
ingest
organ
fulli
cook
meat
care
wash
fruit
veget
food
prepar
surfac
variou
anim
model
gondii
transmit
milk
suckl
young
organ
isol
colostrum
well
newborn
anim
becam
asymptomat
infect
nurs
infect
mother
whose
colostrum
contain
gondii
one
report
identifi
gondii
human
milk
question
surround
reliabl
report
transmiss
breastfeed
human
demonstr
breast
milk
may
contain
appropri
antibodi
gondii
given
benign
natur
postnat
infect
absenc
document
transmiss
human
breast
milk
potenti
antibodi
breast
milk
reason
exist
proscrib
breastfeed
mother
known
infect
toxoplasmosi
trichomona
vaginali
flagel
protozoan
produc
vagin
see
chapter
discuss
vagin
frequent
caus
asymptomat
infect
men
women
parasit
found
women
childbear
year
transmit
predominantli
sexual
intercours
transmit
neonat
passag
birth
canal
parasit
often
coexist
std
especi
gonorrhea
infect
pregnanc
take
oral
contracept
difficult
treat
evid
suggest
infect
growth
parasit
enhanc
estrogen
effect
vagin
epithelium
evid
indic
advers
effect
fetu
associ
matern
infect
pregnanc
occasion
femal
newborn
vagin
discharg
first
week
life
caus
vaginali
thought
influenc
effect
matern
estrogen
infant
vagin
epithelium
acquisit
organ
passag
birth
canal
organ
seem
caus
signific
diseas
healthi
infant
document
exist
transmiss
vaginali
via
breast
milk
difficulti
encount
matern
infect
lactat
stem
metronidazol
flagyl
drug
choic
contraind
infant
case
report
describ
treatment
neonat
metronidazol
without
advers
effect
although
topic
agent
contain
povidoneiodin
betadin
sodium
lauryl
sulfat
trichotin
effect
given
douch
cream
suppositori
metronidazol
remain
treatment
choic
aap
advis
use
metronidazol
physician
discret
consid
effect
nurs
infant
unknown
possibl
concern
potenti
concern
metronidazol
disulfiramlik
effect
associ
alcohol
tumorigen
anim
studi
leukopenia
neurolog
side
effect
describ
adult
hand
metronidazol
given
children
beyond
neonat
period
treat
seriou
infect
variou
parasit
entamoeba
histolytica
current
recommend
lactat
women
tri
local
treatment
first
fail
tri
metronidazol
singledos
treatment
produc
peak
level
hour
discard
express
breast
milk
next
hour
recommend
treatment
also
fail
twicedaili
regimen
day
singl
daili
dose
day
recommend
discard
breast
milk
close
dose
time
feed
distant
dose
infant
exclus
breastfe
presum
greater
risk
exposur
metronidazol
partial
breastf
candida
consist
multipl
speci
common
speci
affect
human
includ
c
albican
domin
agent
c
tropicali
c
krusei
c
parapsilosi
well
mani
uncommon
speci
gener
candida
exist
commens
organ
colon
oropharynx
gi
tract
vagina
skin
without
caus
diseas
chang
disrupt
balanc
organ
host
mild
mucocutan
infect
common
ill
lead
vulvovagin
mastiti
uncommonli
oral
mucos
mother
thrush
oral
candidiasi
candid
diaper
rash
infant
invas
candid
infect
occur
infrequ
usual
person
ill
impair
resist
infect
hiv
diabet
mellitu
neutropenia
decreas
cellmedi
immun
prematur
infant
lbw
vlbw
infant
disrupt
normal
mucos
skin
barrier
receiv
antibiot
corticosteroid
invas
diseas
occur
local
spread
may
occur
often
genitourinari
tract
urethra
bladder
uret
kidney
usual
develop
associ
candidemia
bladder
kidney
frequent
involv
dissemin
occur
via
candidemia
care
search
site
infect
made
eg
retina
liver
spleen
lung
mening
transmiss
usual
occur
healthi
individu
colon
candida
direct
contact
contact
oral
vagin
secret
intrauterin
infect
occur
ascend
infect
birth
canal
rare
distinct
syndrom
congenit
candid
infect
exist
often
infant
infect
pass
birth
canal
remain
colon
postnat
transmiss
occur
direct
contact
caregiv
mother
infant
serv
immedi
sourc
recolon
especi
direct
contact
breastfeed
reason
infant
breastfeed
mother
treat
simultan
treat
thrush
vulvovagin
diaper
candidiasi
mastiti
colon
organ
usual
occur
absenc
clinic
evid
infect
simultan
treatment
occur
even
absenc
clinic
evid
candida
infect
colon
appar
uninvolv
individu
breastfeed
dyad
wellcontrol
clinic
trial
defin
appropri
effect
method
treatment
candid
infect
breastfeed
motherinf
pair
list
possibl
treatment
product
extens
includ
mani
anecdot
empir
regimen
face
absenc
data
brent
conduct
survey
member
academi
breastfeed
medicin
concern
respond
approach
diagnosi
treatment
thrush
breastfeed
dyad
respond
reli
histori
physic
examin
infant
third
rate
examin
mother
import
make
diagnosi
report
use
laboratori
test
make
diagnosi
twentyon
percent
respond
report
use
oral
nystatin
infant
mother
asymptomat
almost
half
treat
infant
mother
topic
nystatin
use
oral
nystatin
infant
oral
fluconazol
mother
mother
breast
pain
less
use
oral
fluconazol
infant
mother
therapi
use
respond
recurr
persist
thrush
respond
report
treat
mother
infant
mother
fluconazol
almost
quarter
report
use
therapi
consider
discuss
mammari
candidosiscandidiasi
clinic
diagnosi
candid
involv
breast
signific
pain
breastfeed
presenc
absenc
candida
albican
milk
sampl
ongo
topic
continu
debat
addit
prospect
studi
necessari
clarifi
specif
issu
data
inadequ
make
specif
recommend
variou
clinic
situat
regard
candida
breastfeed
clinic
practic
vari
experi
especi
problemat
clinic
situat
gener
guidelin
follow
see
chapter
discuss
mastiti
treatment
mucocutan
candidiasi
probabl
begin
topic
agent
nystatin
clotrimazol
miconazol
econazol
butaconazol
terconazol
ciclopirox
treatment
continu
least
week
even
obviou
improv
day
failur
often
result
inadequ
therapi
involv
frequenc
applic
care
wash
dri
applic
case
diaper
candidiasi
decreas
contact
skin
moistur
nystatin
oral
suspens
less
effect
treatment
oral
candidiasi
infant
compar
past
supposedli
due
increas
resist
gentian
violet
dilut
appli
breast
paint
onto
infant
mouth
recommend
frequent
topic
prepar
recommend
mother
breast
includ
mupirocin
grapefruit
seed
extract
mixtur
mupirocin
betamethason
ointment
miconazol
powder
control
clinic
trial
efficaci
toxic
avail
good
adher
propos
regimen
topic
agent
fail
infant
mother
sever
affect
pain
decreas
breastfeed
system
therapi
appropri
fluconazol
ketoconazol
commonli
use
system
agent
oral
diaper
candidiasi
vulvovagin
mastiti
fluconazol
better
side
effect
profil
ketoconazol
data
avail
concern
safe
use
children
younger
month
age
even
neonat
prematur
infant
fluconazol
current
approv
use
infant
younger
month
age
sever
invas
infect
infant
amphotericin
b
without
oral
flucytosin
iv
fluconazol
voriconazol
caspofungin
reason
choic
differ
situat
use
itraconazol
infant
adequ
studi
date
matern
use
fluconazol
breastfeed
contraind
small
amount
medicin
compar
usual
infant
dose
reach
infant
breast
milk
amphotericin
caspofungin
therapi
mother
also
contraind
poorli
absorb
gi
tract
whenev
mother
treat
candid
mastiti
vulvovagin
infant
treat
simultan
least
nystatin
oral
suspens
first
choic
medic
predispos
risk
factor
candid
infect
mother
infant
reduc
elimin
improv
chanc
rapid
success
treatment
decreas
likelihood
chronic
recurr
diseas
mother
intervent
might
includ
decreas
sugar
consumpt
stop
antibiot
use
soon
possibl
consum
form
probiot
bacteria
acidophilu
yogurt
milk
pill
form
reestablish
normal
colon
bacteri
flora
infant
breastfeed
enhanc
growth
specif
colon
bacteri
flora
lactobacillu
success
limit
fungal
growth
breastfeed
continu
appropri
support
problemsolv
profession
knowledg
breastfeed
htlvi
htlvii
infecti
diseas
consid
absolut
contraind
breastfeed
develop
countri
primari
rout
transmiss
via
direct
contact
respiratori
dropletsparticl
temporari
separ
mother
infant
may
appropri
whether
infant
breastf
formula
fed
express
breast
milk
given
infant
organismspecif
immunolog
benefit
mother
milk
instanc
time
specif
diagnosi
infect
made
mother
infant
alreadi
expos
organ
provid
express
breast
milk
infant
continu
refer
appendix
f
specif
except
lassa
fever
regard
antimicrobi
therapi
mother
continu
breastfeed
major
medic
commonli
use
adult
use
treat
infect
infant
addit
amount
medic
receiv
infant
via
breast
milk
usual
insignific
almost
instanc
appropri
antimicrobi
agent
treat
mother
also
compat
breastfeed
chosen
unless
risk
infant
transmiss
infecti
agent
via
breast
milk
lead
clinic
signific
ill
infant
document
breastfeed
continu
